Diverticular disease of intestine

K11_DIVERTIC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K57 Hospital discharge: ICD-9 — 562 Hospital discharge: ICD-8 — 562 Cause of death: ICD-10 — K57 Cause of death: ICD-9 — 562 Cause of death: ICD-8 — 562 2 out of 7 registries used, show all original rules.	44303
4. Check minimum number of events None	44303
5. Include endpoints None	44303
6. Filter based on genotype QC (FinnGen only)	44303

Control definitions (FinnGen only)

Control exclude: K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K55-K63
Name in latin: Diverticulosis intestini

NAME	K11_DIVERTIC
CONTROL_EXCLUDE	K11_INTESTOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K57
HD_ICD_9	562
HD_ICD_8	562
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K57
COD_ICD_9	562
COD_ICD_8	562
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diverticular disease of intestine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	299258	178439	118920
Only index persons	261351	157729	103622
Unadjusted period prevalence (%)
Whole population	4.38	5.11	3.32
Only index persons	5.07	5.80	3.96
Median age at first event (years)
Whole population	67.39	68.44	65.76
Only index persons	66.29	67.33	64.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	44303	25442	18861
Unadjusted period prevalence (%)	8.52	8.67	8.31
Median age at first event (years)	65.16	64.30	66.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
23368: Matched controls
179256

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02BE01

ATC

paracetamol; systemic, rectal

2.6

323.0

19874

122562

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

6.2

323.0

1307

1703

C07AB07

ATC

bisoprolol; oral

1.8

323.0

10233

54800

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

8.3

323.0

2084

2083

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

4.7

323.0

2350

4150

J01MA02

ATC

ciprofloxacin; systemic

2.2

323.0

9653

43982

D06

ICPC

Abdominal pain localized other

4.3

323.0

2056

3962

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.7

323.0

5885

14882

JN3AD

NOMESCO Finland

Abdominal CT examination

4.7

323.0

2428

4320

A02BC01

ATC

omeprazole; systemic

2.0

323.0

6075

27341

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

208.6

323.0

634

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

5.1

323.0

1616

2575

K59.09

ICD-10 Finland

Constipation, unspecified

7.9

323.0

1132

1146

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

106.8

323.0

1051

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

129.2

323.0

1848

119

UJF32

NOMESCO Finland

Coloscopy

13.4

323.0

12683

14552

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

323.0

10040

47518

JN3BD

NOMESCO Finland

Extensive abdominal CT

6.0

323.0

4288

6462

G04CA02

ATC

tamsulosin; oral

1.9

323.0

6259

28364

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

8.9

323.0

2103

1978

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.7

323.0

10128

30576

J01DB01

ATC

cefalexin; oral

2.6

323.0

19277

114893

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

7.5

323.0

1082

1145

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.7

323.0

8677

24807

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

7.8

323.0

1563

1636

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

323.0

12594

70962

P01AB01

ATC

metronidazole; oral, rectal

4.2

323.0

12803

40071

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

323.0

6019

25592

N02AX02

ATC

tramadol; systemic, rectal

2.0

323.0

10131

50194

D01

ICPC

Abdominal pain/cramps general

4.4

323.0

2748

5272

45599

ICD-8 Finland

Haemorrhoids

+∞

323.0

345

A02BC03

ATC

lansoprazole; oral

1.9

323.0

6722

30750

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

314.4

323.0

1931

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

323.0

3111

10067

K57

ICD-10 Finland

Diverticular disease of intestine

33.1

323.0

1218

297

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1004.8

323.0

21262

1803

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

10.8

323.0

1346

1010

K92.1

ICD-10 Finland

Melaena

4.6

323.0

1457

2571

D92

ICPC

Diverticular disease

56.8

323.0

507

A02BC02

ATC

pantoprazole; systemic

2.3

323.0

15571

82577

A06AC01

ATC

ispaghula (psylla seeds); oral

4.5

323.0

7400

16767

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.0

323.0

2657

3726

A02BC05

ATC

esomeprazole; systemic

2.0

323.0

9472

45433

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.6

323.0

1981

4491

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

323.0

3497

12180

UJF30

NOMESCO Finland

Ileoscopy through colon

8.5

323.0

3850

4083

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

25.2

323.0

692

217

H02AB06

ATC

prednisolone; systemic

1.7

323.0

10309

55727

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

7.4

323.0

994

1070

K57.0

ICD-10 Finland

Diverticular disease of small intestine with perforation and abscess

430.7

323.0

442

R06.0

ICD-10 Finland

Dyspnoea

2.0

321.4

5098

21802

UJH02

NOMESCO Finland

Anoscopy

5.7

320.8

1022

1420

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

8.0

317.4

798

793

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

310.1

2446

7426

K59.0

ICD-10 Finland

Constipation

5.8

307.4

972

1337

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

296.7

2317

6982

J01AA02

ATC

doxycycline; systemic

1.8

295.7

17695

114399

5621B

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULITIS COLI SINE HAEMORRHAGIA]

+∞

295.3

314

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

293.8

4562

19245

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

621.2

292.5

320

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

292.4

3273

11963

J01MA12

ATC

levofloxacin; systemic

2.0

284.7

4306

17946

K59.1

ICD-10 Finland

Functional diarrhoea

5.4

280.2

943

1397

WX002

NOMESCO Finland

Sedation and analgesia

2.0

274.7

4203

17567

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

274.6

10090

56234

UKC02

NOMESCO Finland

Cystoscopy

2.1

273.0

3787

15200

6453

FHL

Radical surgery of hemorrhoids

163.7

272.5

316

B01AB05

ATC

enoxaparin; parenteral

1.8

269.5

6247

30292

SPAT1263

SPAT

Sampling

1.7

268.1

8238

43545

A06AD11

ATC

lactulose; oral

2.3

266.7

2906

10448

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

265.9

1616

4116

C03CA01

ATC

furosemide; systemic

1.8

263.2

5669

26792

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

10.0

262.9

577

451

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

262.4

5791

27587

R03AC02

ATC

salbutamol; inhalant

1.6

262.3

10901

62538

JFB46

NOMESCO Finland

Resection of sigmoid colon

17.0

262.0

456

209

5621A

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULOSIS COLI]

+∞

259.5

276

M79.6

ICD-10 Finland

Pain in limb

1.7

258.7

7066

35968

N03AX16

ATC

pregabalin; oral

1.9

254.5

4952

22560

K56.7

ICD-10 Finland

Ileus, unspecified

153.2

254.0

296

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

253.5

5556

26352

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

8.1

252.0

623

601

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.2

250.3

1060

2000

A02BA02

ATC

ranitidine; systemic

1.9

249.3

4296

18712

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

6.8

248.0

693

806

A06AC51

ATC

ispaghula, combinations; systemic

3.9

244.9

1115

2249

XKD00

NOMESCO Finland

Uroflowmetry

1.9

237.1

4043

17501

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

235.4

3314

13301

M54.5

ICD-10 Finland

Low back pain

1.7

233.2

6489

32987

R10.0

ICD-10 Finland

Acute abdomen

4.9

232.0

840

1349

C05AA08

ATC

fluocortolone; rectal, topical

2.1

230.0

3069

12033

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

225.5

4741

22039

S18

ICPC

Laceration/cut

1.6

225.5

8318

45622

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

5.5

225.3

743

1072

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

222.7

4368

19824

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

222.5

7749

41819

K60.1

ICD-10 Finland

Chronic anal fissure

24.1

221.0

344

111

K60.3

ICD-10 Finland

Anal fistula

108.2

220.9

265

J01DA01

ATC

[U] cefalexin; systemic

1.6

219.1

13572

84381

N05CF01

ATC

zopiclone; oral

1.7

216.3

6604

34315

C10AA01

ATC

simvastatin; oral

1.6

216.1

8737

48905

K63.5

ICD-10 Finland

Polyp of colon

21.2

215.9

349

128

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

213.2

1978

6507

N06AX11

ATC

mirtazapine; oral

1.7

212.1

6315

32544

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

7.7

211.6

542

553

J01CA04

ATC

amoxicillin; systemic

1.6

210.1

16904

111350

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

207.1

2182

7656

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

203.0

2440

9103

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

556.4

196.9

216

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

196.4

5590

28326

R53

ICD-10 Finland

Malaise and fatigue

1.9

193.5

3663

16326

R42

ICD-10 Finland

Dizziness and giddiness

1.8

193.4

3924

17906

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

192.3

3461

15151

AA1AD

NOMESCO Finland

CT of head and brain

1.7

188.7

4545

21886

K30

ICD-10 Finland

Functional dyspepsia

2.3

188.0

2004

7053

K57.5

ICD-10 Finland

Diverticular disease of both small and large intestine without perforation or abscess

102.5

186.6

225

C08CA01

ATC

amlodipine; oral

1.6

186.0

7033

38316

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

185.9

4466

21474

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.3

184.4

1034

2466

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

184.4

10394

62141

A07EC02

ATC

mesalazine; oral, rectal

3.0

183.5

1161

3022

G47.3

ICD-10 Finland

Sleep apnoea

1.7

183.3

4986

24857

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

183.0

3425

15174

JF2BD

NOMESCO Finland

Extensive colon CT

17.6

181.6

312

138

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

3.2

180.2

1057

2607

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

179.9

4325

20772

C10AA05

ATC

atorvastatin; oral

1.5

177.3

7767

43722

R51.80

ICD-10 Finland

Headache

2.0

176.1

2577

10409

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

175.5

7984

45314

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

175.4

3834

17860

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

168.1

4560

22633

M01AH05

ATC

etoricoxib; oral

1.5

167.6

12674

79978

M04AA01

ATC

allopurinol; systemic

1.9

167.2

2829

12057

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

167.1

4238

20623

R4110

NOMESCO Finland

Physiotherapy

1.6

165.7

5351

27836

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

164.3

4505

22404

SPAT1153

SPAT

Removal of sutures

1.6

164.2

6133

33086

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

164.2

4009

19278

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

162.4

7233

40659

R50.9

ICD-10 Finland

Fever, unspecified

1.9

161.1

2731

11635

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

160.7

2758

11802

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

15.6

159.6

286

142

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

159.0

1832

6665

N03AX12

ATC

gabapentin; oral

1.8

158.7

2983

13176

C01DA14

ATC

isosorbide mononitrate; oral

1.8

158.4

2973

13127

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

158.0

4767

24305

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

157.9

5190

27062

M25.5

ICD-10 Finland

Pain in joint

1.6

157.4

5483

29012

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

157.4

1825

6658

A03CA02

ATC

clidinium and psycholeptics; oral

2.7

157.2

1204

3534

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.8

157.0

739

1528

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

156.5

4892

25168

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

155.2

7709

44287

R01AD09

ATC

mometasone; nasal

1.5

155.0

8812

52100

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

154.9

2198

8741

J01FA06

ATC

roxithromycin; oral

1.5

154.9

8277

48299

WX110

NOMESCO Finland

Local anesthesy

1.5

153.9

13857

89803

SPAT1301

SPAT

No procedures

1.6

151.5

5564

29774

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.9

150.7

2614

11209

M01AB05

ATC

diclofenac; systemic, rectal

1.4

150.4

14401

94239

G04CA01

ATC

alfuzosin; oral

1.8

149.4

2900

12926

K62.1

ICD-10 Finland

Rectal polyp

33.1

149.3

214

K56.0

ICD-10 Finland

Paralytic ileus

624.7

148.1

162

K61.0

ICD-10 Finland

Anal abscess

30.0

147.9

217

M02AA07

ATC

piroxicam; topical

1.5

147.6

7244

41390

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

147.3

1942

7486

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

145.9

3177

14692

G44.2

ICD-10 Finland

Tension-type headache

1.9

143.2

2306

9612

M01AE02

ATC

naproxen; oral, rectal

1.4

142.9

11455

72085

UJF92

NOMESCO Finland

Capsular endoscopy

5.5

142.7

465

660

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

142.3

2090

8411

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

142.0

5306

28431

L03

ICPC

Low back symptom/complaint

1.6

141.7

4061

20333

ZXA00

NOMESCO Finland

Right side

1.6

140.7

5278

28301

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

140.3

3351

15921

M03BX02

ATC

tizanidine; oral

1.4

139.7

13060

84436

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

139.5

4614

23973

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

139.5

7593

44205

K55.2

ICD-10 Finland

Angiodysplasia of colon

205.1

139.2

159

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

139.2

2222

9225

B01AA03

ATC

warfarin; systemic

1.7

138.5

3847

19083

L17

ICPC

Foot/toe symptom/complaint

1.6

137.8

4347

22305

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

137.3

3400

16321

K64.0

ICD-10 Finland

First degree haemorrhoids

8.5

137.2

328

299

XF402

NOMESCO Finland

ECG with work load test

1.9

136.8

2208

9204

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

136.6

2242

9403

R31

ICD-10 Finland

Unspecified haematuria

1.9

135.0

2142

8869

M48.0

ICD-10 Finland

Spinal stenosis

1.9

134.7

2180

9093

R02

ICPC

Shortness of breath/dyspnoea

2.0

134.3

2031

8256

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.9

133.6

925

2547

ZXA05

NOMESCO Finland

Left side

1.6

132.5

4926

26293

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

132.3

5007

26838

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

132.2

7087

41009

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

131.6

2185

9197

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

130.1

5369

29340

R07.3

ICD-10 Finland

Other chest pain

2.1

130.0

1739

6727

SPAT1325

SPAT

Vaccination

1.5

130.0

5610

30968

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

26.9

129.5

195

J01FF01

ATC

clindamycin; systemic

1.5

128.5

5389

29545

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

127.7

2944

13806

B01AC04

ATC

clopidogrel; oral

1.7

127.0

2996

14144

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

126.7

3867

19619

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

125.9

2350

10295

JAH00

NOMESCO Finland

Laparotomy

4.2

125.6

521

959

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

125.6

7678

45491

SPAT1254

SPAT

Administration of medicine

1.8

125.5

2359

10359

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

125.5

2361

10372

JFB00

NOMESCO Finland

Partial resection of small intestine

7.7

125.2

317

318

A03FA02

ATC

cisapride; oral, rectal

2.2

125.1

1414

5079

C10AC01

ATC

colestyramine; oral

4.3

124.3

510

929

M01AX17

ATC

nimesulide; oral

1.5

123.6

4806

25859

D11

ICPC

Diarrhoea

2.0

123.5

1751

6929

UJD02

NOMESCO Finland

Gastroscopy

2.6

123.1

971

2892

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

123.0

670

1559

K29.7

ICD-10 Finland

Gastritis, unspecified

3.1

122.8

741

1858

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

122.2

3584

17972

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

122.0

4817

25998

M01AC06

ATC

meloxicam; systemic, rectal

1.4

121.6

7362

43465

WX320

NOMESCO Finland

Spinalanesthesy

1.6

121.2

4150

21645

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

120.9

4672

25080

C07AB02

ATC

metoprolol; systemic

1.6

120.5

3878

19913

R05

ICD-10 Finland

Cough

1.6

119.4

3384

16805

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

119.1

1510

5702

M01AX05

ATC

glucosamine; oral

1.7

119.0

3225

15818

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

119.0

2065

8814

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

118.7

1966

8250

H02AB07

ATC

prednisone; oral

1.7

118.5

2772

13029

H02AB04

ATC

methylprednisolone; systemic

1.7

116.9

2824

13400

J02AC01

ATC

fluconazole; systemic

1.4

115.4

7115

42046

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.3

114.4

643

1532

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

114.3

2085

9045

A07EA06

ATC

budesonide; oral, local oral

3.4

114.2

614

1414

J01FA10

ATC

azithromycin; systemic

1.4

112.7

11217

72049

N05BA04

ATC

oxazepam; oral

1.5

112.3

4370

23437

207

Kela drug reimbursment

Chronic arrhythmias

1.7

111.8

2432

11169

JAH01

NOMESCO Finland

Laparoscopy

2.7

111.6

864

2543

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

111.5

3692

19049

A10BA02

ATC

metformin; oral

1.5

111.5

5435

30609

T90

ICPC

Diabetes non-insulin dependent

1.5

110.9

4410

23757

4556A

ICD-9 Finland

Haemorrhoids, Unspecified haemorrhoids without mention of complication

+∞

110.8

118

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

110.5

2993

14653

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

110.2

3666

18931

205

Kela drug reimbursment

Chronic hypertension

1.5

109.9

5334

30000

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

109.3

3915

20577

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

108.8

1931

8291

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

108.0

2550

11999

56210

ICD-8 Finland

Diverticula of intestine, Diverticulum (diverticulosis) coli

+∞

108.0

115

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

107.9

6029

34854

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

107.6

3388

17244

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.3

107.5

597

1409

R05FB02

ATC

cough suppressants and expectorants

1.4

107.4

7418

44610

R03BB04

ATC

tiotropium bromide; inhalant

1.8

107.3

2033

8924

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

3.8

107.3

501

1028

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

107.3

3648

18927

J01FA09

ATC

clarithromycin; systemic

1.4

107.0

6133

35617

C09CA01

ATC

losartan; oral

1.5

107.0

4490

24457

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

106.9

5882

33887

SPAT1312

SPAT

General health counselling

1.5

106.8

5287

29820

M10.9

ICD-10 Finland

Gout, unspecified

2.1

106.5

1362

5156

UJG02

NOMESCO Finland

Proctoscopy

4.8

106.3

392

641

A28

ICPC

Limited function/disability NOS

1.8

105.5

2192

9911

M01AH02

ATC

rofecoxib; oral

1.7

105.5

2399

11156

N02AA05

ATC

oxycodone; systemic

1.7

105.3

2505

11803

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

104.3

2665

12816

4550A

ICD-9 Finland

Haemorrhoids, Internal haemorrhoids without mention of complication

+∞

104.2

111

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

104.0

737

2057

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.7

103.9

389

646

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

103.9

1399

5408

L15

ICPC

Knee symptom/complaint

1.6

103.8

3436

17693

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

102.9

7665

46623

R11

ICD-10 Finland

Nausea and vomiting

2.2

102.4

1149

4103

R35

ICD-10 Finland

Polyuria

2.2

102.3

1218

4468

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

102.0

1866

8088

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

101.7

1974

8729

K59.01

ICD-10 Finland

Constipation outlet obstruction type

59.0

101.1

130

R13

ICD-10 Finland

Dysphagia

2.2

100.9

1169

4237

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

100.7

1796

7716

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

100.4

2821

13918

K57.8

ICD-10 Finland

Diverticular disease of intestine, part unspecified, with perforation and abscess

839.2

100.3

109

K60.2

ICD-10 Finland

Anal fissure, unspecified

8.3

99.5

240

223

R06AE07

ATC

cetirizine; oral

1.4

99.4

7789

47709

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

99.4

2266

10532

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

99.0

2272

10579

N06AB04

ATC

citalopram; systemic

1.5

98.9

3931

21104

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.8

98.9

2100

9553

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

98.7

1383

5432

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

+∞

98.6

105

SPAT1255

SPAT

Intravenous administration of medicine

2.1

98.4

1239

4655

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

98.3

1102

3934

R01AD08

ATC

fluticasone; nasal

1.4

98.2

5302

30339

J01MA06

ATC

norfloxacin; oral

1.7

97.9

2358

11135

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

97.5

19294

137253

A04

ICPC

Weakness/tiredness general

1.8

97.4

1846

8092

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

97.3

5478

31589

L13

ICPC

Hip symptom/complaint

1.7

97.0

2417

11527

N06AX21

ATC

duloxetine; oral

1.8

97.0

1920

8538

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

96.7

2788

13834

K62.0

ICD-10 Finland

Anal polyp

38.3

96.7

134

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.2

96.3

399

734

JHA00

NOMESCO Finland

Anal or perianal incision

14.8

96.2

175

J01MA14

ATC

moxifloxacin; systemic

1.8

96.2

1761

7627

JHD20

NOMESCO Finland

Incision of fistula-in-ano

82.7

95.9

118

ZX120

NOMESCO Finland

Intravenous

1.8

95.8

1720

7401

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

95.8

2030

9223

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

95.8

945

3173

JN4BD

NOMESCO Finland

Extensive body CT

1.8

95.6

1996

9025

I84

ICD-10 Finland

Hemorrhoids

3.4

95.5

516

1193

L08

ICPC

Shoulder symptom/complaint

1.6

95.1

3339

17400

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

94.1

1952

8804

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

93.4

2886

14571

B01AF02

ATC

apixaban; oral

1.9

93.2

1514

6286

R52.9

ICD-10 Finland

Pain, unspecified

2.0

93.1

1393

5608

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

8.1

92.8

227

216

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

4.9

92.6

329

517

JFB43

NOMESCO Finland

Left hemicolectomy

10.4

92.5

197

146

L01

ICPC

Neck symptom/complaint

1.7

92.3

2140

9984

K62.3

ICD-10 Finland

Rectal prolapse

27.3

92.2

138

A11

ICPC

Chest pain NOS

2.0

92.2

1244

4809

E0000UV

ATC

1.4

92.0

6879

41658

R33

ICD-10 Finland

Retention of urine

1.9

91.9

1576

6672

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.2

91.6

532

1298

XF404

NOMESCO Finland

Ambulatory ECG

1.8

91.4

1664

7191

N30.0

ICD-10 Finland

Acute cystitis

1.8

91.3

1840

8220

AN1

Coronary angiography

1.7

91.1

2158

10128

WX892

NOMESCO Finland

Monitored bed care

2.0

91.1

1381

5586

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

90.9

5022

28788

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

5.9

90.8

277

363

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

90.6

10794

70319

R05

ICPC

Cough

1.5

90.3

3586

19201

N05CF02

ATC

zolpidem; oral

1.5

90.2

3230

16890

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

90.2

4315

24038

M79.1

ICD-10 Finland

Myalgia

1.7

90.1

2071

9634

L28

ICPC

Limited function/disability (L)

1.7

89.8

2371

11474

SPAT1260

SPAT

Consultation of another employee

1.6

89.5

2906

14842

K57.4

ICD-10 Finland

Diverticular disease of both small and large intestine with perforation and abscess

380.0

89.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

89.2

3574

19169

K55.8

ICD-10 Finland

Other vascular disorders of intestine

746.3

89.1

SPAT1053

SPAT

Memory test

1.7

88.8

2003

9263

C09AA05

ATC

ramipril; oral

1.4

88.4

4560

25773

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

88.4

1888

8588

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

88.2

13698

92628

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

88.2

2244

10747

JEA00

NOMESCO Finland

Appendectomy

2.0

88.0

1177

4531

I20.09

ICD-10 Finland

Unstable angina

2.1

88.0

1096

4095

R60.0

ICD-10 Finland

Localized oedema

1.8

87.8

1761

7853

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.6

87.6

2746

13892

N06AA09

ATC

amitriptyline; systemic

1.8

87.2

1712

7581

J01EA01

ATC

trimethoprim; systemic

1.5

86.9

3875

21254

D07AC01

ATC

betamethasone; topical

1.4

86.7

6426

38764

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

86.2

1533

6566

R03BA05

ATC

fluticasone; inhalant

1.5

85.8

3174

16706

K62.7

ICD-10 Finland

Radiation proctitis

35.6

85.4

120

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

85.3

2894

14924

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

85.1

3023

15756

A02BC04

ATC

rabeprazole; oral

1.8

85.0

1527

6561

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

84.9

1816

8256

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

84.3

1344

5534

A01

ICPC

Pain general/multiple sites

2.0

84.3

1151

4468

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

84.3

4556

25950

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

84.3

9918

64222

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

84.2

1006

3689

G04CB02

ATC

dutasteride; oral

1.9

84.2

1394

5821

R03BA02

ATC

budesonide; inhalant

1.5

84.0

3083

16191

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

83.9

1371

5697

N81.6

ICD-10 Finland

Rectocele

2.3

83.7

822

2750

D12

ICPC

Constipation

3.2

83.5

476

1146

6451

FHL

Dilatation

72.8

83.4

104

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

82.8

1690

7569

M01AB55

ATC

diclofenac, combinations; oral

2.0

82.5

1208

4820

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

82.3

1074

4091

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

14.4

82.1

151

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

82.0

1720

7771

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

3.9

81.9

364

716

SPAT1310

SPAT

Counselling related to known health issue

1.4

81.5

5275

31024

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

81.1

467

1133

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

81.1

3300

17723

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

81.0

1827

8438

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

80.8

1094

4229

R15

ICD-10 Finland

Faecal incontinence

4.2

80.5

330

602

C10AA07

ATC

rosuvastatin; oral

1.4

80.1

4440

25375

G04BD12

ATC

mirabegron; oral

1.8

80.0

1510

6592

L04AX01

ATC

azathioprine; systemic

2.4

79.6

768

2547

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

79.1

1634

7346

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

79.0

1599

7139

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

78.8

1734

7947

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

78.6

3584

19701

D16

ICPC

Rectal bleeding

3.8

78.4

369

763

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

78.1

2058

9934

A07AA02

ATC

nystatin; oral

2.1

77.9

1005

3809

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

+∞

77.9

A01AB09

ATC

miconazole; local oral

1.8

77.6

1419

6128

SPAT1104

SPAT

Monitoring of emergency patient

2.0

77.4

1130

4500

SPAT1216

SPAT

Assessment of functional ability

1.6

76.9

2231

11046

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

76.8

1292

5422

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

76.5

9111

58806

ZXA10

NOMESCO Finland

Bilateral

1.5

76.3

3002

15980

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

76.2

4927

28911

R03DC03

ATC

montelukast; oral

1.5

75.2

2737

14315

56211

ICD-8 Finland

Diverticula of intestine, Diverticulitis coli

+∞

75.1

P20

ICPC

Memory disturbance

1.8

74.6

1554

6997

N05CD07

ATC

temazepam; oral

1.6

74.4

2199

10929

A02BA04

ATC

nizatidine; systemic

1.8

74.3

1437

6320

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.8

74.3

524

1457

N17

ICPC

Vertigo/dizziness

1.8

74.2

1497

6671

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.2

74.2

428

1040

5650B

ICD-9 Finland

Anal fissure and fistula, Anal fissure[FISSURA ANI TYPICA]

+∞

74.1

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.9

74.1

1262

5317

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

73.8

1714

7977

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

73.3

1168

4807

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

73.3

5060

29995

SPAT1097

SPAT

Recording of ECG

1.6

73.2

2407

12287

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

73.2

2892

15401

J20

ICD-10 Finland

Acute bronchitis

1.7

72.5

1553

7051

C03DA01

ATC

spironolactone; oral

1.7

72.5

1789

8469

K65.0

ICD-10 Finland

Acute peritonitis

4.8

72.4

262

421

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

72.4

1180

4895

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

72.3

1211

5073

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

71.9

3115

16909

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

71.9

1118

4558

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

71.9

2008

9833

Z01.7

ICD-10 Finland

Laboratory examination

1.7

71.9

1794

8520

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.6

71.8

270

452

J01MA01

ATC

ofloxacin; systemic

1.7

71.8

1634

7556

K02.1

ICD-10 Finland

Caries of dentine

1.3

71.7

10568

69996

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

71.7

1330

5769

WZA90

NOMESCO Finland

Other doctors statement

1.4

71.6

3859

21873

R03AC03

ATC

terbutaline; inhalant

1.6

71.5

2384

12203

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

71.4

1213

5106

A98

ICPC

Health maint/preventive medicine

1.5

71.4

20684

150804

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

71.1

3482

19375

N32.1

ICD-10 Finland

Vesicointestinal fistula

17.8

70.8

120

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

70.6

1827

8762

C09CA06

ATC

candesartan; oral

1.4

70.6

3898

22188

N41.1

ICD-10 Finland

Chronic prostatitis

2.7

70.4

538

1571

U02

ICPC

Urinary frequency/urgency

1.7

70.4

1647

7678

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

69.7

1029

4115

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

69.6

1074

4364

C10AX09

ATC

ezetimibe; oral

1.6

69.6

1987

9781

R01AD12

ATC

fluticasone furoate; nasal

1.4

69.5

5196

31159

1470

FHL

Rectoscopy

16.4

69.3

121

B01AF01

ATC

rivaroxaban; oral

1.6

69.2

1908

9307

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

69.0

1241

5325

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

68.9

4532

26598

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

68.7

1567

7249

G04BD08

ATC

solifenacin; oral

2.0

68.2

1011

4044

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

68.1

5832

35706

K22.1

ICD-10 Finland

Ulcer of oesophagus

3.2

68.0

386

927

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

6.4

67.9

195

237

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

67.7

1001

4003

R63.4

ICD-10 Finland

Abnormal weight loss

2.6

67.6

545

1642

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

67.1

2080

10450

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

67.1

1167

4949

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

67.1

1163

4925

Z71.8

ICD-10 Finland

Other specified counselling

1.4

67.1

3766

21477

D07AC13

ATC

mometasone; topical

1.3

67.0

5327

32224

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.6

67.0

2103

10600

K51.5

ICD-10 Finland

Left sided colitis

2.7

66.8

484

1369

N06AB10

ATC

escitalopram; oral

1.4

66.7

3275

18209

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

66.6

1581

7394

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.6

66.4

527

1573

I50.0

ICD-10 Finland

Congestive heart failure

1.8

66.4

1185

5068

D02

ICPC

Abdominal pain epigastric

2.1

66.3

827

3088

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

66.3

736

2610

M01AB01

ATC

indometacin; systemic, rectal

1.7

66.2

1525

7071

K58

ICD-10 Finland

Irritable bowel syndrome

3.6

66.2

330

717

R96

ICPC

Asthma

1.8

65.7

1316

5848

JF2BB

NOMESCO Finland

Clongraphy with duple contrast

31.4

65.3

JFA42

NOMESCO Finland

Endoscopic injection in colon

11.3

65.2

133

C09AA02

ATC

enalapril; systemic

1.4

65.2

3580

20322

R55

ICD-10 Finland

Syncope and collapse

1.6

64.8

1707

8220

J45

ICD-10 Finland

Asthma

1.7

64.7

1519

7080

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

64.6

988

3998

B01AB10

ATC

tinzaparin; parenteral

1.8

64.5

1161

4979

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

64.2

2081

10563

R04.0

ICD-10 Finland

Epistaxis

1.8

64.1

1206

5251

JN4AD

NOMESCO Finland

Body CT examination

1.8

64.0

1307

5844

M01AC01

ATC

piroxicam; systemic, rectal

1.5

63.7

2464

13026

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

63.6

1817

8935

H02

ICPC

Hearing complaint

1.6

63.6

1744

8485

KED22

NOMESCO Finland

Transurethral resection of prostate

1.8

63.1

1208

5288

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

62.7

1065

4478

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

62.5

937

3765

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

62.4

1075

4540

L57.0

ICD-10 Finland

Actinic keratosis

1.7

62.4

1362

6213

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

62.4

11732

79543

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

62.3

2206

11430

M02AA10

ATC

ketoprofen; topical

1.5

62.2

2764

15042

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.2

62.1

257

474

R12

ICD-10 Finland

Heartburn

1.8

62.1

1078

4566

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

62.1

443

1241

A07EA02

ATC

hydrocortisone; rectal

2.9

61.7

408

1089

R74

ICPC

Upper respiratory infection acute

1.4

61.5

4264

25182

JHD10

NOMESCO Finland

Myotomy of anal sphincter

34.8

61.2

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

6.1

60.9

179

225

WX402

NOMESCO Finland

General anaesthesia

1.4

60.9

2886

15907

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

60.8

3519

20138

Z01.2

ICD-10 Finland

Dental examination

1.3

60.7

7061

45002

N06AX16

ATC

venlafaxine; oral

1.5

60.5

2275

11942

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

60.5

1023

4293

SPAT1262

SPAT

Handing over of treatment supplies

1.4

60.3

3105

17386

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

60.3

1663

8101

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.1

59.9

365

924

K56.2

ICD-10 Finland

Volvulus

256.0

59.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

59.6

858

3395

N05BA01

ATC

diazepam; systemic, rectal

1.5

59.5

2229

11690

K64.2

ICD-10 Finland

Third degree haemorrhoids

7.9

59.4

147

144

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

59.3

13506

93423

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

59.1

1672

8199

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

59.0

927

3790

S29

ICPC

Skin symptom/complaint other

1.5

58.9

2514

13560

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

58.6

1348

6241

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.0

58.6

794

3066

A10BH01

ATC

sitagliptin; oral

1.6

58.6

1636

7992

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

58.5

1378

6422

C08CA02

ATC

felodipine; oral

1.6

58.3

1503

7186

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

58.2

2030

10476

K64.1

ICD-10 Finland

Second degree haemorrhoids

4.9

58.1

206

325

H81

ICPC

Excessive ear wax

1.5

57.6

2525

13691

L86

ICPC

Back syndrome with radiating pain

1.9

57.6

872

3516

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

57.6

1298

5975

C05AA01

ATC

hydrocortisone; rectal, topical

1.9

57.6

904

3696

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

57.3

2407

12937

U05

ICPC

Urination problems other

2.1

57.3

686

2518

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

57.2

681

2492

M54.2

ICD-10 Finland

Cervicalgia

1.8

57.1

1156

5151

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

57.1

578

1965

R03BA01

ATC

beclometasone; inhalant

1.5

56.6

2407

12962

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

56.4

1130

5018

J05AB01

ATC

aciclovir; systemic

1.4

56.3

3393

19527

C08CA13

ATC

lercanidipine; oral

1.5

56.2

2032

10566

A03

ICPC

Fever

1.5

56.0

2307

12341

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

55.9

740

2833

A29

ICPC

General symptom/complaint other

1.6

55.9

1667

8280

S21

ICPC

Skin texture symptom/complaint

1.6

55.8

1833

9321

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

55.6

620

2203

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

55.6

1083

4763

M54

ICD-10 Finland

Dorsalgia

1.6

55.6

1701

8500

H25.8

ICD-10 Finland

Other senile cataract

1.7

55.0

1339

6298

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

55.0

1288

5991

A46

ICD-10 Finland

Erysipelas

1.5

54.8

2414

13093

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.1

54.7

333

842

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

54.6

2171

11522

K56.1

ICD-10 Finland

Intussusception

161.5

54.6

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

54.5

1129

5063

Z50.1

ICD-10 Finland

Other physical therapy

1.9

54.4

920

3861

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

54.4

949

4024

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

54.3

10839

73479

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

54.2

2159

11462

N41.0

ICD-10 Finland

Acute prostatitis

2.6

53.9

430

1290

R19.4

ICD-10 Finland

Change in bowel habit

2.9

53.8

355

948

J01DA06

ATC

[U] cefuroxime; systemic

1.4

53.5

2597

14354

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

53.4

8350

54982

Angiography of the heart and coronary arteries

1.7

53.4

1101

4929

A07AA09

ATC

vancomycin; oral

4.0

53.4

232

449

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

53.3

440

1346

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

53.2

1383

6624

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.7

53.2

1171

5351

Z02.4

ICD-10 Finland

Examination for driving licence

1.4

53.1

3876

23005

L16

ICPC

Ankle symptom/complaint

1.6

53.0

1455

7068

C10AA04

ATC

fluvastatin; oral

1.7

53.0

1319

6242

A10BH05

ATC

linagliptin; oral

2.0

52.9

729

2834

K80

ICPC

Cardiac arrhythmia NOS

1.8

52.8

1052

4663

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

52.7

2609

14468

A02BX02

ATC

sucralfate; oral

2.0

52.5

696

2665

R06.5

ICD-10 Finland

Mouth breathing

1.6

52.4

1633

8196

SPAT1285

SPAT

Provision of consultation response

1.9

51.9

826

3390

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

8.1

51.9

126

120

C07AA05

ATC

propranolol; systemic

1.4

51.9

3108

17844

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

51.7

1080

4858

L12

ICPC

Hand/finger symptom/complaint

1.5

51.6

2100

11195

JHD00

NOMESCO Finland

Anal dilatation

12.4

51.5

100

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

51.3

986

4318

R21

ICPC

Throat symptom/complaint

1.4

51.3

2558

14203

N05BA12

ATC

alprazolam; oral

1.5

51.1

1690

8601

UJF34

NOMESCO Finland

Left colonoscopy

6.3

50.9

147

181

B82

ICPC

Anaemia other/unspecified

2.7

50.9

366

1033

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

50.8

1421

6935

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

50.7

629

2343

N05AH04

ATC

quetiapine; oral

1.4

50.7

2558

14233

4553A

ICD-9 Finland

Haemorrhoids, External haemorrhoids without mention of complication

+∞

50.7

M54.3

ICD-10 Finland

Sciatica

1.8

50.6

976

4279

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

50.3

758

3052

A99

ICPC

Disease/condition unspecnature/site

1.7

50.1

1146

5292

L05

ICPC

Flank/axilla symptom/complaint

1.9

50.0

810

3345

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

49.9

1309

6281

WX722

NOMESCO Finland

PEEP

1.8

49.9

888

3793

56510

ICD-8 Finland

Anal fissure and fistula, Anal fistula

+∞

49.7

K22.7

ICD-10 Finland

Barrett oesophagus

3.3

49.7

267

618

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

7.5

49.6

126

129

A11CC03

ATC

alfacalcidol; systemic

2.5

49.5

418

1293

K50.8

ICD-10 Finland

Other Crohn disease

3.6

49.5

244

527

D29

ICPC

Digestive symptom/complaint other

3.0

49.4

315

823

C10AA03

ATC

pravastatin; oral

1.7

49.4

1062

4817

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.6

49.4

401

1214

K62.2

ICD-10 Finland

Anal prolapse

19.9

49.2

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

49.2

676

2626

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

3.6

49.1

237

503

R07.0

ICD-10 Finland

Pain in throat

1.8

49.1

848

3582

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

48.7

763

3115

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

48.5

1199

5660

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

48.5

423

1332

R06AX27

ATC

desloratadine; oral

1.3

48.4

4426

27121

R19.5

ICD-10 Finland

Other faecal abnormalities

4.2

48.4

197

359

SPAT1211

SPAT

Application of soft bandage

1.6

48.4

1303

6297

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

48.3

826

3480

N01

ICPC

Headache

1.7

48.2

1150

5375

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

48.2

1704

8804

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

48.2

6532

42145

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

48.1

654

2529

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

48.0

4900

30484

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

48.0

595

2217

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

48.0

768

3159

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

47.9

1007

4533

D18

ICPC

Change in faeces/bowel movements

3.2

47.9

278

681

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

47.9

982

4388

E66.8

ICD-10 Finland

Other obesity

1.8

47.6

891

3868

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

47.5

1822

9584

TK800

NOMESCO Finland

Hemodialysis

2.5

47.5

411

1290

JKA20

NOMESCO Finland

Cholecystectomy

2.3

47.3

463

1547

M10

ICD-10 Finland

Gout

1.9

47.2

785

3274

R03BA08

ATC

ciclesonide; inhalant

1.6

47.2

1319

6435

K63.9

ICD-10 Finland

Disease of intestine, unspecified

14.4

47.2

K92.0

ICD-10 Finland

Haematemesis

2.4

47.2

442

1447

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

47.0

1581

8069

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

47.0

1899

10097

D64.8

ICD-10 Finland

Other specified anaemias

3.2

47.0

269

653

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

46.8

1114

5202

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

46.8

552

2012

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

46.7

580

2162

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

46.6

3371

19931

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

46.6

1439

7196

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.5

46.4

1995

10745

N04BC05

ATC

pramipexole; oral

1.7

46.4

1080

5014

R00.2

ICD-10 Finland

Palpitations

1.7

46.3

975

4393

N06AB06

ATC

sertraline; oral

1.5

46.1

1633

8434

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

46.1

2214

12191

N06AB03

ATC

fluoxetine; oral

1.5

46.0

2031

10995

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.8

45.9

882

3859

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

45.7

1201

5761

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

45.7

608

2330

R52.2

ICD-10 Finland

Other chronic pain

2.2

45.5

482

1673

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

45.5

915

4066

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

45.4

1463

7394

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

11.2

45.4

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

45.3

1369

6810

R04.2

ICD-10 Finland

Haemoptysis

2.0

45.3

590

2243

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

6.8

45.2

123

140

Z00.0

ICD-10 Finland

General medical examination

1.4

45.2

2834

16366

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.9

45.1

767

3222

56419

ICD-8 Finland

Functional disorders of intestines, Colon irritabile aliud sive NUD

+∞

45.0

U07

ICPC

Urine symptom/complaint other

1.9

45.0

744

3097

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

44.9

1156

5518

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

44.9

1543

7917

D07AD01

ATC

clobetasol; topical

1.4

44.8

2571

14622

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

44.7

1040

4824

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.6

44.7

216

460

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

44.7

1610

8349

K62.6

ICD-10 Finland

Ulcer of anus and rectum

7.0

44.6

118

129

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

44.6

2186

12076

A01AB04

ATC

amphotericin B; local oral

1.9

44.5

724

2996

K78

ICPC

Atrial fibrillation/flutter

1.7

44.5

1074

5036

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

44.3

801

3435

A07DA03

ATC

loperamide; oral

2.0

44.2

579

2205

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

70.5

44.2

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

44.0

1508

7727

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

44.0

1013

4686

B03XA02

ATC

darbepoetin alfa; parenteral

2.6

43.9

337

988

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

43.9

1235

6036

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

43.8

1050

4913

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

43.8

1270

6252

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

43.8

499

1791

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

43.7

832

3631

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

43.7

1360

6813

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.7

43.7

967

4423

SPAT1131

SPAT

Colonoscopy

2.2

43.6

487

1734

C03AA03

ATC

hydrochlorothiazide; oral

1.5

43.6

1456

7419

JF2AD

NOMESCO Finland

Colon CT

15.0

43.6

SPAT1101

SPAT

Orthostatic test

2.0

43.6

579

2219

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.2

43.5

500

1802

I20.00

ICD-10 Finland

Unstable angina

2.1

43.5

537

1998

I50

ICD-10 Finland

Heart failure

2.4

43.4

413

1361

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

43.3

783

3359

S06.0

ICD-10 Finland

Concussion

1.5

43.2

1513

7792

D93

ICPC

Irritable bowel syndrome

4.6

43.0

161

271

K60.0

ICD-10 Finland

Acute anal fissure

7.4

42.9

110

115

A02BDXX

ATC

2.0

42.7

572

2201

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

42.7

559

2131

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

42.6

809

3530

D01AC02

ATC

miconazole; topical

1.5

42.5

1385

7014

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

42.5

2037

11203

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.6

42.5

1167

5666

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

42.4

914

4144

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

42.4

375

1190

S22.3

ICD-10 Finland

Fracture of rib

1.6

42.4

1114

5344

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.5

42.3

351

1077

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1.5

42.3

1886

10224

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

42.3

7775

51734

P06

ICPC

Sleep disturbance

1.5

42.2

1447

7415

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.9

41.9

283

767

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

2.8

41.9

297

832

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

41.9

1258

6246

K61.1

ICD-10 Finland

Rectal abscess

125.5

41.8

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

41.7

1318

6627

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

5.6

41.7

130

178

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

41.6

460

1630

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

41.6

671

2770

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

41.6

925

4237

H01

ICPC

Ear pain/earache

1.5

41.4

1376

7000

H03AA01

ATC

levothyroxine sodium; systemic

1.3

41.4

3417

20576

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.9

41.3

643

2620

C08CA05

ATC

nifedipine; systemic

1.6

41.3

1053

5011

H26.4

ICD-10 Finland

After-cataract

1.7

41.3

1001

4697

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

41.2

267

707

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

28.8

41.1

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

41.0

1720

9204

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.6

41.0

326

977

R51

ICD-10 Finland

Headache

1.8

41.0

700

2947

D50

ICD-10 Finland

Iron deficiency anaemia

2.9

41.0

266

705

A02BA03

ATC

famotidine; systemic

1.9

40.8

641

2620

-60

ICPC

Result test/procedure

1.7

40.7

831

3708

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

40.7

4774

30138

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.0

40.6

566

2212

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

40.5

716

3048

TFP20

NOMESCO Finland

Cardiodefibrillation

1.6

40.5

1203

5957

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

40.4

2375

13548

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

40.4

838

3759

5651A

ICD-9 Finland

Anal fissure and fistula, Anal fistula[FISTULA ANI]

+∞

40.3

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

40.3

1249

6251

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.7

40.1

296

849

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

40.1

856

3871

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.2

40.0

456

1640

A91

ICPC

Abnormal result investigation NOS

1.9

40.0

612

2477

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

40.0

721

3093

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

40.0

789

3484

R01AD01

ATC

beclometasone; nasal

1.4

40.0

2608

15138

N19

ICD-10 Finland

Unspecified kidney failure

2.1

39.9

506

1904

H13

ICPC

Plugged feeling ear

1.4

39.9

2695

15729

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

39.8

727

3132

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

39.8

775

3408

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

3.4

39.8

208

473

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

8.5

39.7

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

4.9

39.7

138

215

J05AB11

ATC

valaciclovir; oral

1.4

39.5

2012

11182

A97

ICPC

No disease

1.4

39.5

2069

11561

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.9

39.4

649

2698

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

39.4

486

1809

D25

ICPC

Abdominal distension

3.0

39.3

246

637

SPAT1058

SPAT

PEF monitoring instruction

1.6

39.3

1140

5610

K29.8

ICD-10 Finland

Duodenitis

3.7

39.2

184

383

JFB30

NOMESCO Finland

Right hemicolectomy

3.4

39.2

204

462

L29

ICPC

Musculoskeletal sympt/complt other

1.6

39.2

1041

5006

WX290

NOMESCO Finland

Other blockade of nerve

1.2

39.1

7767

51976

SPAT1229

SPAT

Assessment of need for aid

1.6

39.1

1037

4988

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

39.0

1399

7240

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

39.0

978

4633

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

3.6

38.9

188

401

SPAT1304

SPAT

Counselling and guidance related to ageing

1.8

38.9

737

3213

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

38.9

1361

7005

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

38.9

1296

6596

M10.0

ICD-10 Finland

Idiopathic gout

1.9

38.6

569

2271

3AC01

NOMESCO Finland

3.5

38.6

196

436

5608A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]

+∞

38.5

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

38.5

844

3849

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

38.4

550

2173

K85

ICPC

Elevated blood pressure

1.4

38.4

2058

11541

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.2

38.4

425

1507

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

38.3

695

2986

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

38.3

1364

7047

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.5

38.3

191

419

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

38.2

493

1869

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.8

38.2

714

3097

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

38.2

627

2605

WW500

NOMESCO Finland

Blood transfusion

1.9

38.2

572

2299

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

38.2

653

2751

C08DB01

ATC

diltiazem; oral

1.7

38.1

781

3488

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

38.1

660

2794

K63.8

ICD-10 Finland

Other specified diseases of intestine

48.0

38.1

6455

FHL

Perianal fistula surgery

20.4

38.0

JF1AD

NOMESCO Finland

Small bowel CT

6.7

38.0

104

120

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

37.9

355

1163

SFA00

NOMESCO Finland

Small filling

1.4

37.9

2094

11810

UJF02

NOMESCO Finland

Peroral enteroscopy

5.5

37.9

120

168

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.3

37.8

381

1293

K62.4

ICD-10 Finland

Stenosis of anus and rectum

321.3

37.8

Z93.3

ICD-10 Finland

Colostomy status

4.6

37.8

141

237

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

37.7

2260

12922

M01AX01

ATC

nabumetone; oral

1.8

37.7

686

2951

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

37.7

460

1704

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.9

37.7

599

2458

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

37.6

478

1801

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

37.6

366

1223

4559X

ICD-9 Finland

Haemorrhoids, Residual haemorrhoidal skin tags

+∞

37.5

E000001

ATC

1.3

37.5

3182

19211

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

37.5

865

4004

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

39.2

37.4

H29

ICPC

Ear symptom/complaint other

1.5

37.3

1371

7131

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

6.6

37.2

103

121

H02.3

ICD-10 Finland

Blepharochalasis

1.7

37.2

870

4040

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

37.1

1261

6445

R10

ICD-10 Finland

Abdominal and pelvic pain

3.3

37.1

204

483

JF1BD

NOMESCO Finland

Very extensive small bowel CT

5.7

37.0

114

154

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

37.0

1236

6290

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

36.9

390

1353

E86

ICD-10 Finland

Volume depletion

2.4

36.9

346

1135

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

36.9

519

2037

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.0

36.9

482

1836

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

36.8

909

4285

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

36.8

1288

6627

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.6

36.7

1117

5559

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

36.7

411

1466

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.7

36.7

817

3740

WZC30

NOMESCO Finland

Teaching

1.4

36.7

2168

12367

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

36.6

1134

5668

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

36.6

909

4294

M15

ICD-10 Finland

Polyarthrosis

1.9

36.6

581

2385

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

36.6

844

3906

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.1

36.6

458

1715

K29.6

ICD-10 Finland

Other gastritis

3.3

36.6

195

451

JG1JG

NOMESCO Finland

MRI of rectal function (MR defecography)

11.5

36.5

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

36.5

881

4131

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

36.4

571

2332

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

36.4

1374

7192

R01AD11

ATC

triamcinolone; nasal

1.5

36.3

1420

7486

SPAT1360

SPAT

Extensive global examination

1.6

36.2

1048

5157

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

36.0

222

569

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

35.9

1033

5072

Z94.0

ICD-10 Finland

Kidney transplant status

3.0

35.8

221

567

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

35.8

952

4579

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.5

35.7

300

929

UJK02

NOMESCO Finland

ERCP

2.2

35.7

380

1326

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.7

35.7

782

3565

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

35.7

447

1674

D01AE16

ATC

amorolfine; topical

1.4

35.7

1855

10344

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

35.6

510

2015

L02

ICPC

Back symptom/complaint

1.5

35.5

1162

5885

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.8

35.4

160

323

D07XC01

ATC

betamethasone, combinations; topical

1.4

35.4

2065

11747

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.9

35.4

232

619

L90

ICPC

Osteoarthrosis of knee

1.7

35.4

829

3853

SPAT1043

SPAT

Audiometry

1.5

35.3

1339

7011

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

35.2

1416

7511

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

35.1

368

1274

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.1

35.1

423

1559

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

35.1

507

2011

J01CA08

ATC

pivmecillinam; oral

1.2

35.0

5025

32390

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

35.0

669

2924

A12AA04

ATC

calcium carbonate; oral

2.5

35.0

285

867

JAD10

NOMESCO Finland

Repair of incisional hernia

4.0

34.9

150

290

127

Kela drug reimbursment

Transplant complication

2.5

34.9

288

884

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

34.8

602

2546

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

34.8

856

4033

R03AC12

ATC

salmeterol; inhalant

1.7

34.8

713

3185

EBA00

NOMESCO Finland

Extraction of tooth

1.2

34.8

5489

35751

C07AG02

ATC

carvedilol; oral

1.6

34.8

933

4500

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

34.7

638

2755

K07

ICPC

Swollen ankles/oedema

1.9

34.7

513

2052

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.2

34.6

196

474

SPAT1167

SPAT

Insertion of urinary catheter

2.0

34.6

456

1744

N06AX03

ATC

mianserin; oral

1.7

34.6

756

3446

N07CA01

ATC

betahistine; oral

1.5

34.5

1102

5553

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

34.4

3005

18195

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

34.4

1272

6624

I25.2

ICD-10 Finland

Old myocardial infarction

1.5

34.4

1218

6281

K51.8

ICD-10 Finland

Other ulcerative colitis

3.0

34.4

212

544

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.1

34.3

417

1543

K63.2

ICD-10 Finland

Fistula of intestine

290.4

34.1

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

34.0

1556

8467

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

34.0

1580

16324

X58

ICD-10 Finland

Exposure to other specified factors

1.4

34.0

2169

12525

L04

ICPC

Chest symptom/complaint

1.7

33.9

750

3429

B80

ICPC

Iron deficiency anaemia

2.7

33.9

249

715

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

33.9

710

3194

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

33.8

1161

5948

A08

ICPC

Swelling

1.9

33.8

518

2101

L04AA06

ATC

mycophenolic acid; systemic

2.4

33.8

310

1005

R03AC13

ATC

formoterol; inhalant

1.7

33.8

778

3598

N81.1

ICD-10 Finland

Cystocele

1.8

33.8

642

2803

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

33.8

857

4074

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

33.7

189

452

G04BD07

ATC

tolterodine; oral

1.8

33.7

631

2740

D01BA02

ATC

terbinafine; oral; topical

1.2

33.6

4617

29589

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.4

33.6

295

935

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

33.6

711

3209

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

33.6

595

2538

JGC01

NOMESCO Finland

Laparoscopic rectopexy

14.2

33.6

J46

ICD-10 Finland

Status asthmaticus

2.1

33.6

388

1405

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

33.5

1451

7808

N20.1

ICD-10 Finland

Calculus of ureter

1.7

33.5

682

3039

C09DA01

ATC

losartan and diuretics; oral

1.4

33.5

1681

9307

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

33.5

1449

7795

L14

ICPC

Leg/thigh symptom/complaint

1.6

33.5

941

4594

R95

ICPC

Chron obstructive pulmonary disease

2.0

33.5

431

1635

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

33.4

3805

23850

H92.0

ICD-10 Finland

Otalgia

1.8

33.4

637

2782

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.8

33.4

577

2441

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

33.4

563

2361

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

33.3

1098

5569

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

33.2

201

510

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5670

22044

1.83

317.78

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5676

22131

1.82

314.92

1.9

1.7

—

(40761511) CBC panel - Blood by Automated count

35734

217099

1.91

313.62

20.0

12.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2550

7368

2.39

313.27

1.1

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

36619

224389

2.04

312.42

13.9

9.9

u/l

25.8

26.6

9.94

35625

215692

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

34338

206185

1.77

311.09

5.6

4.6

mmol/l

6.1

6.0

27.88

31358

187805

(3003396) Base excess in Arterial blood by calculation

5891

23363

1.79

308.57

7.2

7.1

mmol/l

1.0

1.1

1.65

4690

18379

(3042936) Bacteria identified in Isolate by Culture

6728

27744

1.73

308.31

2.2

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

19839

94053

1.80

307.65

6.6

5.7

58.0

57.4

9.40

18440

87752

(3023103) Potassium [Moles/volume] in Serum or Plasma

36736

219777

2.42

307.65

24.8

15.3

mmol/l

4.0

1.09

36111

213534

(40768797) Stomach Pathology biopsy report

8590

24546

2.69

307.65

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

3148

9171

2.39

307.65

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

10918

46099

1.79

307.65

4.5

3.4

—

(3000850) Epithelial cells [#/volume] in Urine

10985

41188

2.06

307.65

2.9

2.5

e6/l

4.8

5.1

1.64

9687

35836

(3001604) Monocytes [#/volume] in Blood

21268

98708

1.92

307.65

6.5

5.6

e9/l

0.6

4.97

18282

84653

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17530

78870

1.85

307.65

4.5

3.3

ng/l

68.6

70.8

0.05

12856

54845

(3015377) Calcium [Moles/volume] in Serum or Plasma

14964

68807

1.71

307.65

3.4

mmol/l

2.4

0.40

12746

60007

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16947

82094

1.65

307.65

2.4

2.1

nmol/l

78.8

1196.7

0.50

15028

73313

(3007164) IgA [Mass/volume] in Serum or Plasma

8919

31740

2.12

307.65

1.5

g/l

2.6

2.5

0.47

4922

19477

(3026493) Urate [Moles/volume] in Serum or Plasma

12269

56317

1.65

307.65

3.0

2.6

umol/l

4424.4

4909.3

0.59

10488

48769

(3022217) INR in Platelet poor plasma by Coagulation assay

7122

27393

1.88

307.65

29.3

24.2

inr

1.4

0.04

974

3547

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2936

8458

2.41

307.65

1.7

1.6

g/l

1.6

1.76

2521

7171

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

32159

159714

2.75

307.65

9.0

7.1

u/l

78.5

79.4

2.79

30590

149702

(40758558) Short blood count panel - Blood

12047

50303

1.85

307.65

6.8

—

(3006504) Eosinophils/100 leukocytes in Blood

19636

92763

1.80

307.65

6.7

5.8

2.8

2.9

1.74

18246

86257

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8600

31352

2.05

307.65

3.4

2.8

e6/l

2.7

2.6

0.30

4837

16812

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9695

39278

1.84

307.65

4.5

3.5

ng/l

443.0

548.3

0.92

7888

31318

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5630

16534

2.47

307.65

2.7

2.4

u/l

40.8

51.8

0.86

4849

14020

(3014111) Lactate [Moles/volume] in Serum or Plasma

4820

16958

2.01

307.65

6.9

7.0

mmol/l

1.3

1.4

1.27

4651

16327

(3021601) Nitrite [Presence] in Urine by Test strip

20412

98490

1.77

307.65

6.3

4.6

estimate

0.0

3.27

3254

18466

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

33401

196606

1.79

307.65

7.1

5.7

mmol/mol

40.5

40.1

10.06

30955

181156

(3013115) Eosinophils [#/volume] in Blood

21945

102421

1.94

307.65

6.7

5.7

e9/l

0.2

0.22

19172

89207

(3021960) Folate [Moles/volume] in Serum or Plasma

11256

45932

1.87

307.65

1.7

1.5

nmol/l

20.5

20.2

1.08

9686

39150

(42870588) Differential panel, method unspecified - Blood

15249

67283

1.82

307.65

6.4

5.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

36714

219080

2.45

307.65

24.5

15.1

mmol/l

139.6

139.8

37.50

36132

213230

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8984

37083

1.79

307.65

3.0

mmol/l

2.5

0.98

7659

32418

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

28346

155494

1.73

307.65

4.4

3.8

pmol/l

14.9

2.95

25726

140897

(3023520) Reticulocytes [#/volume] in Blood

4717

16235

2.05

307.65

2.5

2.6

e9/l

70.7

69.0

2.18

3528

12289

(3044640) Blood type and Crossmatch panel - Blood

14965

61361

1.99

307.65

2.8

2.2

—

(3009261) Glucose [Presence] in Urine by Test strip

20670

99588

1.79

307.65

4.7

3.4

estimate

0.0

0.99

3169

17930

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

22009

102842

1.94

307.65

7.8

6.3

mmol/l

1.2

5.02

19017

86002

(3015736) pH of Urine

16700

75395

1.81

307.65

4.3

3.2

5.7

5.8

0.18

(3019069) Monocytes/100 leukocytes in Blood

19736

93257

1.80

307.65

7.0

6.1

8.8

8.7

3.51

18380

87122

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

19216

83496

2.02

307.65

2.3

1.9

pmol/l

94.5

95.8

2.79

10277

42769

(3013512) EKG study

12741

61052

1.57

307.65

4.7

3.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

1997

4423

3.10

307.65

1.2

1.1

—

(3022145) Colonoscopy Study observation

8577

16680

4.08

307.65

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4877

17473

1.97

307.65

2.6

2.2

ug/l

5.8

8.0

10.47

4216

15240

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2125

4259

3.44

307.65

1.4

ug/g

275.2

264.4

1.32

1274

2513

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

25098

103814

2.64

307.65

6.3

6.0

umol/l

11.3

11.8

6.80

23939

98201

(3027945) Reticulocytes/100 erythrocytes in Blood

6390

21693

2.14

307.65

2.4

1.8

3.33

5586

19144

(3048689) Calprotectin [Mass/mass] in Stool

7201

16612

3.29

307.65

2.3

2.1

ug/g

154.5

134.8

2.82

5754

12930

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6210

21384

2.10

307.65

2.9

2.6

umol/l

8.0

9.6

6.21

5399

18615

(3014576) Chloride [Moles/volume] in Serum or Plasma

6860

24974

2.00

307.65

7.4

6.8

mmol/l

104.4

104.5

0.93

6749

24367

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7976

31803

1.83

307.65

2.0

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

17051

58832

2.62

307.65

2.8

2.4

u/l

55.8

59.8

9.93

15881

53936

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1977

4389

3.10

307.65

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

14397

60290

1.92

307.65

3.3

2.9

ng/l

1564.3

1425.8

2.63

12452

51655

(3019309) Folate [Moles/volume] in Red Blood Cells

9506

37374

1.91

307.65

1.8

1.7

nmol/l

1138.2

1176.7

3.31

7196

28158

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

33107

189461

1.95

307.65

5.5

4.5

mu/l

2.0

2.2

1.49

30353

172398

(3031040) Bacteria [#/volume] in Urine by Automated count

28503

130093

2.60

307.65

5.7

4.0

e6/l

1668.2

1404.3

0.23

337

2004

(3018418) pH of Serum or Plasma

13421

61234

1.69

307.65

4.8

3.9

7.4

0.24

2088

12021

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13840

63239

1.69

307.65

2.3

2.1

u/l

183.0

218.7

3.69

12958

59065

(3006315) Basophils [#/volume] in Blood

21389

99212

1.93

307.65

6.5

5.6

e9/l

0.0

0.51

18414

85091

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5983

22861

1.87

307.65

4.1

4.3

u/l

237.4

248.2

5.73

5608

21639

(3024354) Oxygen [Partial pressure] in Venous blood

4286

14513

2.08

307.65

3.6

2.9

kpa

4.5

4.6

0.80

4137

14017

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10027

35957

2.14

307.65

1.3

1.2

u/ml

1.4

1.8

2.64

2418

9812

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

36187

206995

2.76

307.65

21.8

13.0

mg/l

27.3

24.3

50.00

32076

162005

(3014765) Yersinia sp identified in Stool by Organism specific culture

1992

4419

3.10

307.65

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5815

20478

2.04

307.65

3.4

3.9

ug/l

13.7

31.9

5.27

4714

16583

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5121

17823

2.04

307.65

4.5

3.5

kpa

5.8

0.76

4968

17299

(3002032) Base excess in Venous blood by calculation

5148

17742

2.06

307.65

4.5

3.5

mmol/l

1.8

1.9

1.41

4292

14440

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

33505

199169

1.74

307.65

19.1

12.5

ml/min/173m2

75.8

78.9

135.80

28769

163862

(3030467) Casts [#/volume] in Urine by Automated count

14143

55210

2.09

307.65

3.7

3.0

e6/l

0.4

1.56

11048

41111

(3013826) Glucose [Moles/volume] in Serum or Plasma

25408

119949

2.12

307.65

5.6

4.4

mmol/l

6.7

6.8

10.35

24136

112380

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10036

42368

1.77

307.65

1.9

1.6

mg/l

1.2

1.3

0.32

7798

32870

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7835

27814

2.08

307.65

3.0

2.3

g/l

2.3

3.26

7229

25612

(3022096) Basophils/100 leukocytes in Blood

19144

89976

1.80

307.65

6.8

5.8

0.7

0.02

17797

83686

(3035350) Ketones [Presence] in Urine by Test strip

20384

98144

1.78

307.65

4.6

3.4

estimate

0.0

0.12

3144

18170

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7412

25959

2.10

307.65

3.1

2.4

21.2

23.2

22.45

6412

22019

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11699

46336

1.96

307.65

2.7

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12951

46033

2.29

307.65

2.7

2.1

mg/l

3.1

3.0

11.84

11168

39013

(3000991) Gas panel - Venous blood

4615

16242

2.00

307.65

8.4

8.2

—

(3023368) Bacteria identified in Blood by Culture

14146

54243

2.13

307.65

4.7

4.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

20185

93191

1.89

307.65

7.0

5.7

mmol/l

1.2

4.94

18390

84088

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4721

11993

2.83

307.65

1.7

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

12122

51550

1.81

307.65

4.7

3.6

88.1

89.8

9.26

11824

50248

(3002030) Lymphocytes/100 leukocytes in Blood

20084

95571

1.80

307.65

6.9

5.9

26.9

27.6

15.26

18593

88725

(3022948) Iron [Moles/volume] in Serum or Plasma

8382

30090

2.08

307.65

3.0

2.4

umol/l

12.0

13.9

2.12

7755

27750

(3026008) Bacteria identified in Urine by Culture

14290

58270

1.98

307.65

3.7

2.9

—

(3002582) Erythrocytes [#/volume] in Urine

15112

60292

2.07

307.65

3.8

3.1

e6/l

60.8

107.1

4.16

11999

45656

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

24572

132942

1.59

307.65

3.7

2.9

u/l

55.2

51.4

6.46

22749

123212

(3032080) INR in Blood by Coagulation assay

18851

84568

1.91

307.65

10.3

8.8

inr

1.3

0.00

4727

24100

(3013707) Erythrocyte sedimentation rate by Westergren method

29823

151751

2.21

307.65

5.1

3.8

mm/h

13.9

12.6

35.03

27677

139938

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9421

33876

2.11

307.65

3.1

2.6

e6/l

1.1

1.2

0.61

5611

19190

(3001122) Ferritin [Mass/volume] in Serum or Plasma

17853

78151

1.94

307.65

3.5

2.6

ug/l

140.5

148.8

2.80

16406

71816

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3605

9448

2.69

307.65

2.6

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19984

92775

1.86

307.65

4.5

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

24976

114575

2.20

307.65

9.2

8.8

e9/l

4.4

4.1

45.33

21760

99397

(3024561) Albumin [Mass/volume] in Serum or Plasma

20453

87162

2.15

307.65

5.4

4.4

g/l

35.1

35.4

7.32

19091

80419

(40768804) Tissue Pathology biopsy report

17502

82311

1.74

307.65

2.3

2.1

—

(3012544) pH of Venous blood

5241

18596

2.00

307.65

4.5

3.5

7.4

0.25

(3019198) Lymphocytes [#/volume] in Blood

21685

101537

1.92

307.65

6.5

5.6

e9/l

1.9

0.02

19013

88648

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13829

64861

1.64

307.65

3.4

3.1

u/l

33.9

34.5

0.43

13033

61377

(3026782) Osmolality of Urine

10091

38411

2.00

307.65

3.2

2.6

mosm/kgh2o

546.4

549.7

0.63

8592

32614

(3018095) Leukocytes [#/volume] in Urine

17073

69868

2.09

307.65

4.4

3.5

e6/l

81.3

110.9

4.35

12851

49240

(3037467) Urinalysis macro (dipstick) panel - Urine

28565

137765

2.33

307.65

5.5

4.0

—

(36304419) Bacteria [Presence] in Urine

13568

53457

2.04

307.65

3.7

2.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5897

23418

1.79

307.41

7.2

7.1

kpa

5.1

1.79

5644

22335

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6379

25943

1.75

306.62

6.9

5.4

mmol/l

1.0

2.37

5888

24082

(3027801) Oxygen [Partial pressure] in Arterial blood

5890

23405

1.79

306.29

7.2

7.1

kpa

11.9

12.3

7.54

5628

22320

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7609

32584

1.68

303.38

3.3

3.2

mmol/l

0.8

8.92

7056

30296

(3020564) Creatinine [Moles/volume] in Serum or Plasma

36592

224577

2.01

301.31

24.6

15.5

umol/l

82.5

78.2

70.45

36581

224473

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4106

14663

1.96

296.42

4.3

3.7

ng/l

97.8

90.5

3.77

3538

12518

(3003327) Ova and parasites identified in Stool by Light microscopy

1841

4697

2.68

291.06

1.7

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15107

76601

1.50

288.71

5.1

3.6

—

(3019150) Specific gravity of Urine by Refractometry

9355

42724

1.59

286.63

5.3

3.8

kg/l

1.0

0.54

1533

6250

(3016502) Oxygen saturation in Arterial blood

5296

20810

1.80

283.99

7.6

7.5

95.4

95.6

0.65

5146

20031

(3044889) 12 lead EKG panel

26606

151519

1.50

281.90

4.6

3.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7287

31424

1.66

280.12

2.2

2.0

30.2

29.8

4.20

7069

30530

(36660697) Celiac disease serology panel - Serum

3660

12823

1.99

277.97

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4439

16652

1.87

275.52

2.6

g/l

66.2

66.6

2.70

3991

15172

(3020682) Albumin/Creatinine [Ratio] in Urine

13683

68459

1.50

275.27

4.1

3.9

mg/mmol

10.1

8.2

4.21

8704

42844

(3020779) Urea [Moles/volume] in Serum or Plasma

4611

17645

1.83

268.35

8.6

6.8

mmol/l

10.8

10.1

7.87

4346

16734

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1840

4893

2.57

267.90

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3785

13651

1.93

263.82

2.5

2.4

—

(40761535) Cells panel - Urine sediment

4367

16591

1.84

259.48

4.2

3.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2701

8747

2.13

252.05

4.6

3.8

mmol/l

24.1

24.2

0.24

2431

7790

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3270

11386

1.99

251.52

1.8

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4654

18199

1.79

251.26

2.4

2.1

g/l

0.2

1.89

4298

16872

(3012516) Albumin [Mass/volume] in Urine

12947

64977

1.48

250.28

3.4

3.2

mg/l

511.9

373.0

2.23

8356

40472

(3004716) Salmonella sp identified in Stool by Organism specific culture

2417

7563

2.19

245.43

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4827

19205

1.76

245.40

8.0

7.9

g/l

119.7

122.1

12.19

4707

18492

(3021589) Normoblasts [#/volume] in Blood

17121

91056

1.44

241.91

11.4

9.2

e9/l

0.0

1.42

13919

74635

(3013139) Helicobacter pylori Ag [Presence] in Stool

3371

12056

1.94

239.69

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

13201

66969

1.46

238.68

3.3

3.1

mmol/l

7.3

7.6

6.96

11045

56010

(3004119) Hemoglobin [Mass/volume] in Venous blood

3331

11911

1.94

236.82

3.9

3.1

g/l

126.6

129.4

9.54

3260

11645

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2697

8999

2.06

232.28

3.1

2.6

1.2

1.3

1.91

2690

8950

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2652

8816

2.07

230.61

3.1

2.6

0.7

0.81

2568

8423

(3007853) Bacteria identified in Skin by Aerobe culture

5476

22975

1.68

228.77

1.9

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4372

17290

1.76

225.57

3.1

2.8

ng/l

228.6

212.1

1.23

3976

15818

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2060

6249

2.25

224.77

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3448

12747

1.87

221.14

8.9

9.1

93.7

93.8

0.40

3440

12697

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3427

12710

1.86

217.45

8.9

9.0

0.7

0.08

3409

12630

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3094

11124

1.92

215.60

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2338

7598

2.11

215.21

2.5

2.2

g/l

7.4

0.50

1724

5661

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2332

7572

2.11

215.13

2.5

2.2

g/l

3.8

3.9

0.33

1669

5389

(3007461) Platelets [#/volume] in Blood

37141

232499

1.90

214.51

31.9

19.3

e9/l

249.5

248.6

1.47

36517

225389

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3427

12768

1.86

214.24

8.8

8.9

1.4

0.02

3407

12682

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2333

7591

2.11

214.05

2.5

2.2

—

(3035941) MCH [Entitic mass]

37144

232628

1.90

211.93

31.7

19.2

30.3

30.4

10.75

36778

228722

(3024731) MCV [Entitic volume]

37146

232662

1.90

211.50

31.8

19.2

91.5

91.3

9.83

36778

228750

(3026361) Erythrocytes [#/volume] in Blood

37146

232677

1.89

211.13

31.9

19.2

e12/l

4.4

4.5

213.05

36390

224771

(3010813) Leukocytes [#/volume] in Blood

37148

232715

1.89

210.60

31.9

19.3

e9/l

7.0

6.7

71.12

36396

224841

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7346

33711

1.55

210.60

1.3

iu/ml

37.8

40.6

0.25

2237

10894

(3000963) Hemoglobin [Mass/volume] in Blood

37147

232739

1.89

209.81

32.1

19.3

g/l

132.6

136.1

307.65

36790

228847

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2206

7081

2.13

209.40

2.5

2.2

g/l

10.1

10.3

1.11

1846

5892

(3037522) Nuclear Ab [Titer] in Serum

5913

25899

1.61

206.57

1.4

1.3

titre

541.4

537.6

0.05

1244

5444

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

34811

214411

1.62

205.09

5.9

5.0

mmol/l

2.6

2.8

136.81

32071

197153

(3009542) Hematocrit [Volume Fraction] of Blood

31154

187564

1.47

199.92

23.1

14.2

38.8

39.8

52.67

20853

132126

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6915

31762

1.54

195.62

1.3

1.2

u/ml

12.3

13.3

0.43

2408

12452

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2162

7159

2.06

188.88

2.5

2.3

g/l

3.1

0.89

1697

5538

(3000494) Fungus identified in Specimen by Culture

5297

23040

1.61

188.84

1.5

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4038

16400

1.71

187.47

2.2

2.3

nmol/l

357.2

375.7

6.21

3663

15140

(3029937) Albumin [Presence] in Urine by Test strip

10674

53875

1.43

187.46

5.3

3.8

estimate

0.0

1.41

3119

17630

(3020961) Endomysium IgA Ab [Titer] in Serum

2183

7275

2.05

187.45

1.1

titre

131.5

240.2

1.71

209

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

32958

201464

1.50

185.39

4.6

4.0

mmol/l

1.4

1.3

45.17

29944

183908

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2892

10679

1.86

184.72

8.9

9.3

mmol/l

24.3

24.4

0.60

2673

9918

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1273

3469

2.48

175.32

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

34063

210217

1.53

174.88

5.2

4.5

mmol/l

4.5

4.7

151.84

31517

194254

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1841

5909

2.12

174.08

2.4

2.2

g/l

37.4

37.7

1.02

1572

5054

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

33831

208533

1.51

173.90

5.2

4.4

mmol/l

1.4

1.5

74.39

31042

191726

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2060

6906

2.03

173.77

3.0

3.4

u/ml

1548.1

2501.8

0.42

1720

5941

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

20534

116504

1.35

172.62

2.7

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

1807

5816

2.11

169.57

3.5

3.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1662

5188

2.18

168.38

2.5

2.3

g/l

0.0

0.00

1513

4777

(3019060) Gas panel - Arterial blood

3403

13559

1.73

168.21

4.7

—

(4010399)

3629

14740

1.70

167.34

1.5

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2609

9615

1.86

167.06

4.1

3.2

mmol/l

25.2

25.3

1.05

2553

9331

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1953

6512

2.04

167.02

2.6

2.4

g/l

0.9

1.0

0.67

1677

5563

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1676

5267

2.16

166.98

2.5

2.3

g/l

0.0

1.17

1516

4789

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2454

8887

1.89

165.77

4.8

3.6

48.2

47.8

0.38

2429

8783

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8850

44059

1.43

163.34

1.8

1.7

pmol/l

39368246.0

30477702.9

0.65

7308

36227

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1759

5713

2.09

161.11

2.5

2.3

g/l

0.0

0.44

1596

5216

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1958

6699

1.99

155.81

3.2

2.8

u/ml

0.3

0.4

1.61

1103

3852

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1926

6672

1.96

147.81

1.1

u/ml

1.2

12.1

1.53

102

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2710

10498

1.77

146.87

2.9

2.7

e6/l

0.2

0.3

3.10

2656

10208

(3005719) IgG [Mass/volume] in Serum or Plasma

3397

14060

1.66

144.89

2.8

2.7

g/l

10.3

10.7

4.65

3120

12833

(3049717) Cytology report of Urine Cyto stain

2191

8002

1.87

143.64

2.6

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5708

26713

1.49

142.80

9.7

6.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3045

12293

1.70

142.47

3.8

3.4

kpa

5.1

5.2

0.61

2788

11353

(3028026) IgM [Mass/volume] in Serum or Plasma

2761

10882

1.74

140.74

2.0

1.9

g/l

1.4

0.04

2512

9885

(3009343) pH of Capillary blood

3002

12128

1.70

139.99

3.8

3.4

7.4

3.23

376

1686

(3034860) Kappa light chains.free [Mass/volume] in Serum

1838

6420

1.94

137.55

3.3

3.4

mg/l

88.1

56.9

0.52

1538

5168

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1835

6407

1.95

137.48

3.3

3.4

mg/l

46.7

44.6

0.11

1533

5161

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

804

1961

2.76

137.38

1.5

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1795

6223

1.96

137.26

3.3

ratio

7.1

3.0

0.39

104

511

(3005988) Vibrio sp identified in Specimen by Organism specific culture

799

1949

2.76

136.50

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

796

1945

2.75

135.56

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

796

1950

2.75

134.91

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1371

4340

2.14

133.73

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

800

1978

2.72

133.27

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2891

11713

1.69

133.13

3.8

3.3

mmol/l

1.6

1.8

2.07

2149

8669

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

812

2032

2.69

132.24

1.5

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

8460

43111

1.38

131.80

5.0

4.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2914

11905

1.67

129.95

7.1

mmol/l

24.7

24.8

0.32

2889

11783

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3102

12910

1.65

128.81

7.4

6.8

mmol/l

24.6

24.7

0.82

2933

12008

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3876

17031

1.57

128.72

2.9

2.6

ml/min/173m2

61.7

64.2

2.93

1639

6588

(3020891) Body temperature

2150

8098

1.81

127.41

5.2

4.6

—

(3002385) Erythrocyte distribution width [Ratio]

28353

172084

1.33

126.84

25.9

16.0

14.0

13.7

121.54

27972

168045

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2123

7997

1.81

125.73

2.1

1.9

ug/l

1.8

2.3

1.07

1868

7035

(3019225) pH of Specimen

4403

20003

1.52

125.62

4.8

4.0

—

(3003338) MCHC [Mass/volume]

28797

175440

1.33

122.83

28.5

16.9

g/l

330.9

332.3

121.92

28597

174005

(3000330) Specific gravity of Urine by Test strip

2536

10215

1.69

118.83

4.4

3.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

1899

7091

1.82

115.49

4.3

4.0

mmol/l

1.4

0.64

1870

6972

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2205

8633

1.74

114.30

1.5

1.6

u/ml

12.2

17.8

1.05

228

(3041096) Erythrocytes [Presence] in Urine by Automated

9922

52842

1.33

113.11

4.2

3.1

—

(3002256) Pathology report gross observation

5606

27238

1.43

112.74

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2655

10985

1.65

112.18

10.1

9.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13714

76436

1.29

111.77

5.5

4.8

ug/l

3.3

3.4

0.16

12269

68589

(3024928) Oxygen saturation in Venous blood

1224

3984

2.07

110.96

3.3

3.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

1670

6148

1.84

106.12

4.5

4.3

mmol/l

3.9

0.44

1599

5771

(3022621) pH of Urine by Test strip

2993

12936

1.58

105.64

3.6

2.7

—

(3022313) Gas panel - Capillary blood

2175

8695

1.70

104.39

4.0

3.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5472

26905

1.41

101.91

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1229

4169

1.99

99.53

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1229

4170

1.99

99.47

1.4

1.3

—

(40768443) Skin Pathology biopsy report

2178

8849

1.67

98.28

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1983

7888

1.70

96.74

2.0

1.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1476

5381

1.85

96.59

1.6

1.5

iu/ml

16.9

15.1

0.17

137

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1730

6667

1.76

94.36

1.5

1.6

titre

238.7

258.3

0.10

292

(3017143) Hepatitis C virus Ab [Presence] in Serum

3856

18049

1.46

93.19

1.7

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1881

7478

1.70

91.86

4.2

3.6

mmol/l

24.8

24.9

1.42

1725

6867

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1774

6949

1.73

91.35

2.4

2.3

ug/l

532.5

576.4

0.15

1679

6556

(3000492) Spirometry study

3946

18658

1.45

90.30

1.6

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1354

4918

1.86

89.57

1.6

e6/l

12233.5

13706.6

0.62

984

3577

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11027

61070

1.28

89.18

4.8

4.2

22.1

22.0

0.27

5449

30091

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

348

668

3.48

88.16

1.1

1.0

—

(3037756) Immunofixation for Serum or Plasma

1204

4286

1.89

84.68

1.6

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

1318

4849

1.83

83.69

3.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1417

5339

1.79

83.26

1.6

iu/ml

18.8

6.0

0.68

347

1166

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1792

7222

1.68

83.06

1.9

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

1363

5098

1.80

82.04

1.2

titre

143.2

128.9

0.16

468

(21494755) Public health laboratory ask at order entry panel

1713

18110

0.61

81.32

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1084

3792

1.92

80.29

1.7

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4575

22656

1.39

80.00

1.7

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

1349

5073

1.79

79.74

1.2

titre

992.1

1009.9

0.03

167

(3037121) Protein [Mass/volume] in Urine

1629

6468

1.70

79.73

2.9

3.0

g/l

0.4

0.3

1.14

691

2728

(3045414) Leukocytes [Presence] in Urine

2094

8895

1.59

78.76

2.1

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

1407

5407

1.75

77.29

5.3

3.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1744

7111

1.66

77.25

2.7

2.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

392

885

2.96

76.94

1.4

1.2

u/l

278.5

393.5

0.64

368

818

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2885

13245

1.48

76.12

2.4

au/ml

28.7

25.5

0.43

112

722

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1173

4286

1.84

76.07

1.1

u/ml

3.7

8.1

3.51

101

548

(3038515) Glucose [Moles/volume] in Venous blood

1168

4271

1.84

75.56

4.3

3.0

mmol/l

7.3

7.7

5.77

1147

4195

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3977

19487

1.39

73.65

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1423

5584

1.72

72.59

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

1203

4512

1.79

71.68

4.2

2.9

mmol/l

1.6

2.49

1178

4421

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2625

11971

1.49

71.42

1.3

au/ml

52.1

49.6

0.20

101

560

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

789

2570

2.06

71.30

1.3

nmol/l

0.2

0.3

1.27

197

(3005322) IgE [Units/volume] in Serum or Plasma

2488

11238

1.50

70.91

1.3

u/ml

215.2

254.3

0.85

2300

10406

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1978

8495

1.57

70.86

5.2

4.8

1.6

1.7

2.02

1890

7974

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

366

835

2.93

70.60

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

367

841

2.92

70.25

1.2

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

784

2574

2.04

69.37

1.3

nmol/l

0.6

1.8

1.18

754

2490

(3007930) Methemoglobin/Hemoglobin.total in Blood

1940

8343

1.57

69.06

5.3

4.8

0.9

0.07

1853

7825

(3033705) Calcium.ionized [Moles/volume] in Venous blood

753

2462

2.05

67.38

2.8

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1101

4103

1.80

66.99

2.7

3.3

u/ml

588.9

987.3

0.74

976

3751

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

728

2359

2.07

66.71

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

271

535

3.38

66.00

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8014

44032

1.26

65.23

3.3

3.0

ug/l

0.7

0.8

3.21

5815

29263

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1016

3734

1.83

64.65

6.3

5.7

iu/ml

727.7

1226.1

0.58

173

567

(3024980) IgG subclass 4 [Mass/volume] in Serum

830

2854

1.95

64.61

1.6

g/l

0.7

0.8

0.77

652

2121

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1352

5434

1.68

63.10

2.7

2.3

g/l

3.7

0.04

1295

5186

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2510

11694

1.45

60.97

3.0

3.4

pmol/l

4.4

2.49

2193

10429

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10014

56786

1.23

60.44

1.7

mmol/l

1.4

4.72

8515

47131

(3021788) Differential panel - Synovial fluid

999

3731

1.80

60.34

1.6

1.5

—

(3036489) Thrombin time

1659

7101

1.58

60.13

2.2

1.9

22.1

21.6

1.25

1459

6202

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1351

5510

1.65

59.61

1.6

g/l

0.2

0.09

1274

5213

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

718

2417

1.99

59.37

2.5

2.0

mg/l

24.7

27.6

0.66

191

665

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1384

5697

1.64

58.89

1.6

g/l

1.2

0.44

1310

5412

(3044927) Protein electrophoresis panel - Urine

598

1903

2.10

57.48

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1890

8413

1.52

57.45

2.0

u/l

38.1

39.4

1.92

1624

7362

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

414

1128

2.45

57.06

3.4

nmol/l

135.4

135.1

0.00

405

1114

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1246

5036

1.66

56.91

3.1

3.0

mmol/l

24.7

24.8

0.12

1077

4459

(3017732) Neutrophils [#/volume] in Blood

2823

13662

1.40

55.43

2.9

2.8

e9/l

4.2

4.0

2.28

2011

10479

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1683

7365

1.54

55.29

1.2

u/ml

0.4

1.0

4.81

157

656

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1269

5192

1.64

55.28

2.7

2.3

202.9

194.3

2.52

1195

4920

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1375

5742

1.61

55.20

2.3

2.1

90.1

91.2

0.95

1286

5330

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4911

25920

1.29

54.09

4.9

4.5

32.2

32.3

0.05

3323

17476

(3017181) Myelocytes/100 leukocytes in Blood

3456

17361

1.35

53.89

4.1

1.0

0.07

1079

4844

(3003181) Sodium [Moles/volume] in Urine

891

3327

1.80

53.86

1.4

1.3

mmol/l

60.4

63.2

1.22

700

2649

(3044941) Cell count panel - Synovial fluid

859

3176

1.81

53.63

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

778

2791

1.87

53.43

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4149

21449

1.32

53.17

3.8

3.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

394

1092

2.41

52.42

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

729

2578

1.89

52.31

6.4

5.8

mg/l

11.9

11.6

1.21

658

2364

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

398

1113

2.39

51.94

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

614

2056

2.00

51.57

3.5

3.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

319

805

2.64

51.36

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

319

805

2.64

51.36

1.5

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

876

3331

1.76

49.84

1.5

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

625

2136

1.96

49.59

3.3

3.2

nmol/l

8.0

8.2

0.03

603

2084

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

581

1941

2.00

49.14

3.6

3.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

170

301

3.76

48.49

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

713

2573

1.86

48.11

1.5

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

710

2567

1.85

47.63

2.5

u/ml

578.9

777.3

0.19

701

2515

(3028626) Oxygen [Partial pressure] in Capillary blood

1064

4328

1.65

47.41

3.0

2.8

kpa

8.0

8.1

0.36

983

4030

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1129

4673

1.62

46.97

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1125

4664

1.62

46.50

1.6

—

(1761868) Lipid panel - Serum or Plasma

10081

76164

0.84

46.20

3.3

2.9

—

(21494434) Karyotype in Bone marrow

512

1672

2.05

46.09

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

822

3154

1.75

45.37

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1121

4672

1.61

45.35

2.3

2.2

g/l

128.6

130.1

1.06

754

3411

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2070

9848

1.42

44.56

3.2

3.5

u/ml

35.8

60.6

4.76

1977

9534

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1219

5212

1.57

44.31

1.3

1.2

u/ml

33.9

38.1

0.18

297

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

761

2876

1.77

44.24

2.9

2.6

u/ml

15168.7

1898.9

0.43

174

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2423

11859

1.38

44.18

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1414

6260

1.52

43.96

5.9

5.7

mmol/l

1.3

1.14

1288

5544

(3021440) Promyelocytes/100 leukocytes in Blood

3229

16561

1.32

43.29

4.1

0.1

0.45

977

4495

(3010375) cycloSPORINE [Mass/volume] in Blood

295

784

2.51

42.96

30.2

27.9

ug/l

108.7

117.3

1.47

256

663

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1080

4523

1.60

42.84

1.7

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

1061

4430

1.61

42.61

2.5

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1114

4709

1.59

42.51

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

608

2174

1.87

42.26

2.0

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3952

20906

1.28

41.99

1.6

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

518

1761

1.97

41.80

3.0

2.6

—

(4035726)

3629

19002

1.30

41.73

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

960

3934

1.64

41.57

1.2

1.3

titre

92.0

139.1

0.62

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1121

4776

1.57

41.37

1.3

1.2

u/ml

2.7

5.6

1.53

105

485

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1133

4842

1.57

41.27

1.3

1.2

u/ml

6.7

6.8

0.00

160

779

(3000093) Morphology [Interpretation] in Blood Narrative

533

1840

1.94

41.16

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

822

3252

1.69

40.70

1.4

1.3

u/l

44.7

32.7

1.02

734

2807

(3023183) Ammonium ion [Moles/volume] in Plasma

996

4151

1.61

40.31

3.4

2.5

umol/l

33.5

33.9

0.19

846

3486

(3026250) Tacrolimus [Mass/volume] in Blood

285

771

2.47

40.05

34.0

34.4

ug/l

7.1

7.4

1.56

247

695

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

816

3239

1.69

39.92

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

311

880

2.36

39.70

1.4

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

962

3991

1.62

39.67

1.2

u/ml

0.8

13.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

311

881

2.35

39.60

1.4

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

964

4007

1.61

39.45

3.3

3.0

nmol/l

0.8

0.09

736

3127

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

958

3976

1.61

39.44

1.2

u/ml

5.9

5.8

0.02

302

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1100

4721

1.56

39.34

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1034

4375

1.58

39.31

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

772

3037

1.70

39.04

1.2

1.3

u/ml

295.0

281.9

0.52

507

1956

(3011985) Renin [Units/volume] in Plasma

684

2602

1.76

38.94

1.4

mu/l

62.6

62.7

0.00

609

2317

(3032057) Clostridioides difficile [Presence] in Stool

162

325

3.32

38.74

1.7

1.8

—

(3051651) Icteric interference index of Serum or Plasma

357

1088

2.19

38.41

3.6

4.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

864

3519

1.64

38.34

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1288

5789

1.49

37.25

1.7

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3042

15818

1.30

36.65

3.9

0.7

0.6

0.64

752

3533

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1210

5399

1.50

36.25

2.0

2.1

mg/l

12.0

11.0

3.41

1113

5016

(3027135) IgG subclass 1 [Mass/volume] in Serum

511

1817

1.88

36.21

1.6

1.4

g/l

6.5

6.9

1.41

380

1241

(3025159) Blasts/100 leukocytes in Blood

3005

15625

1.30

36.20

4.1

0.3

0.07

811

3830

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

577

2134

1.81

36.12

1.1

u/ml

3.4

3.5

0.03

180

1055

(3024139) IgG subclass 3 [Mass/volume] in Serum

510

1815

1.88

36.04

1.6

1.4

g/l

0.4

1.13

384

1243

(3028192) IgG subclass 2 [Mass/volume] in Serum

510

1815

1.88

36.04

1.6

1.4

g/l

2.9

3.0

1.01

381

1240

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

667

2578

1.73

35.97

1.1

g/l

1.5

0.05

597

2339

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

438

1486

1.97

35.63

1.2

titre

268.8

163.7

0.49

(4062490)

508

1813

1.87

35.60

1.6

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

438

1490

1.96

35.36

1.2

titre

160.4

175.7

0.16

246

(3021901) Oxygen saturation in Capillary blood

896

3759

1.60

35.32

3.1

2.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

831

3435

1.62

34.81

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

179

410

2.91

34.59

1.2

pmol/l

320.8

295.6

0.21

129

310

(44806118)

556

2074

1.79

33.88

1.6

1.5

—

(44790049)

556

2075

1.79

33.82

1.6

1.5

—

(44790048)

556

2075

1.79

33.82

1.6

1.5

—

(44790047)

556

2075

1.79

33.82

1.6

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

845

3539

1.60

33.57

1.5

1.4

u/ml

16.3

21.6

0.65

(3045142) Bone marrow Pathology biopsy report

587

2236

1.75

33.34

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

725

2935

1.65

33.00

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

849

3577

1.59

32.91

1.5

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

498

1813

1.83

32.85

2.2

2.4

—

0.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

775

3195

1.62

32.84

3.7

3.3

1.5

1.4

0.40

606

2484

(3010421) pH of Blood

1183

5363

1.48

32.81

4.4

3.8

7.4

0.29

998

4569

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

468

1671

1.87

32.80

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

468

1671

1.87

32.80

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

468

1671

1.87

32.80

1.6

1.7

—

(1616796) Gas panel - Central venous blood

1041

4605

1.51

32.51

4.0

3.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

742

3035

1.64

32.45

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

620

2433

1.70

31.72

1.2

1.3

pmol/l

257.1

268.3

0.45

492

1883

(3006462) Nitrate [Presence] in Urine

292

891

2.18

31.43

4.3

3.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

694

2816

1.65

31.33

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

768

3198

1.61

31.27

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2025

17553

0.75

31.21

1.9

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

520

1954

1.78

30.97

1.4

1.5

iu/ml

37.2

27.5

0.47

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

410

1431

1.91

30.81

1.5

1.6

u/ml

25.1

25.0

0.01

297

(4094501)

1277

5996

1.43

29.49

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

325

1067

2.03

29.06

2.1

umol/l

17.4

28.7

1.07

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1132

5218

1.45

28.86

3.3

2.9

mg/l

1.8

1.6

10.90

1032

4755

(3006270) Folate [Moles/volume] in Blood

450

1655

1.81

28.80

1.3

1.1

nmol/l

346.5

363.9

0.87

361

1379

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

768

3263

1.57

28.78

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

876

3835

1.53

28.75

1.2

u/ml

41.5

45.5

0.23

395

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

568

2240

1.69

28.60

1.8

1.9

u/l

841.1

2969.9

3.07

159

791

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

656

2695

1.63

28.25

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

760

3239

1.57

28.12

1.5

1.4

u/ml

116.3

114.9

0.13

172

758

(4211845)

303

986

2.05

27.77

4.2

2.9

—

(3027315) Oxygen [Partial pressure] in Blood

1031

4713

1.46

27.46

4.6

3.9

kpa

8.5

0.02

1002

4596

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

188

501

2.50

27.45

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1025

4683

1.47

27.38

4.6

3.9

kpa

4.9

5.0

1.45

996

4567

(3012501) Base excess in Blood by calculation

1024

4682

1.46

27.25

4.6

3.9

mmol/l

2.4

2.5

0.63

689

3216

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1270

6053

1.41

26.99

1.8

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

148

353

2.79

26.76

1.2

1.3

mu/l

63.9

64.2

0.01

114

270

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

525

2066

1.70

26.68

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

544

2163

1.68

26.61

1.2

u/l

56.9

63.5

1.05

360

1471

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

647

2698

1.60

26.27

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

247

760

2.17

26.16

2.9

2.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

288

941

2.04

26.15

1.2

1.1

iu/ml

2.9

4.4

1.24

(3010144) Erythrocytes [#/volume] in Synovial fluid

495

1928

1.71

26.12

1.4

e6/l

161127.1

109478.1

0.74

350

1320

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1017

4685

1.45

26.05

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

694

2950

1.57

26.00

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

495

1931

1.71

25.98

3.7

3.3

57.7

58.8

0.40

327

1247

(3045424) Erythrocytes [Presence] in Urine

773

3380

1.53

25.56

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1261

11378

0.73

25.43

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4025

22485

1.21

25.41

1.8

1.7

1.6

1.5

6.84

3356

19681

(3020876) Protein [Mass/time] in 24 hour Urine

453

1738

1.74

25.23

1.9

2.0

g/24h

0.7

1.0

0.57

(3008757) Leukocyte morphology finding [Identifier] in Blood

530

2125

1.67

25.15

4.1

3.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1132

5361

1.41

24.96

2.4

ug/min

125.2

102.1

0.89

660

3142

(3003694) ABO and Rh group [Type] in Blood

8908

53170

1.14

24.79

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

722

3133

1.54

24.73

1.4

—

(3023419) Bacteria identified in Sputum by Culture

613

2563

1.60

24.65

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

561

2299

1.63

24.48

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1070

5041

1.42

24.30

1.4

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

331

1167

1.89

24.26

1.2

u/l

25.3

23.0

0.35

280

1003

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

150

381

2.62

24.17

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

336

1198

1.87

23.82

1.3

titre

69.6

76.7

0.14

104

(3017704) Immunofixation for Urine

313

1092

1.91

23.69

1.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

343

1235

1.85

23.59

1.3

titre

414.7

476.9

0.07

106

(3035320) C reactive protein [Mass/volume] in Body fluid

372

1375

1.80

23.54

2.6

2.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

335

1204

1.85

23.18

1.2

u/l

87.3

89.1

0.11

291

1053

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2756

14944

1.24

23.17

2.4

2.1

nmol/l

12.0

12.7

4.12

2385

13253

(3039162) Centromere protein B Ab [Units/volume] in Serum

575

2405

1.60

23.12

1.2

u/ml

58.9

51.9

0.26

151

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

503

2041

1.64

22.85

1.6

1.7

—

(3014271) Vancomycin [Susceptibility]

292

1016

1.92

22.31

3.2

2.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

234

752

2.07

22.29

5.2

4.6

mg/l

835.3

2353.6

0.76

170

536

(3006922) Hepatitis E virus Ab [Presence] in Serum

340

1247

1.82

22.10

1.1

—

(3042733) HLA Ab [Presence] in Serum

203

619

2.18

22.07

5.2

4.9

—

(40761536) Microorganisms panel - Urine sediment

3066

16902

1.22

22.01

5.0

3.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

735

3287

1.49

21.92

1.4

1.5

—

(3016038) Potassium [Moles/volume] in Urine

337

1243

1.81

21.52

1.2

1.1

mmol/l

33.1

34.7

0.56

271

1070

(40767503) Oxygen content in Capillary blood by calculation

948

4469

1.42

21.50

2.8

2.5

16.0

16.4

1.86

527

2328

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

634

2765

1.53

21.30

1.2

u/ml

2.9

3.9

0.91

215

941

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

468

1910

1.63

20.84

1.6

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

387

1505

1.71

20.66

1.1

—

(3020491) Glucose [Moles/volume] in Blood

367

1410

1.74

20.46

1.8

1.9

mmol/l

7.0

7.2

0.42

258

991

(3048879) Bone marrow aspiration report

187

578

2.15

19.74

1.5

1.8

—

(3008295) Osmolality of Serum or Plasma

444

1816

1.63

19.64

1.4

mosm/kgh2o

274.1

278.9

3.34

314

1442

(4015189)

176

535

2.19

19.36

2.1

2.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

156

454

2.29

19.01

1.1

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

602

2671

1.50

18.73

1.2

u/ml

3.0

4.0

3.46

282

1171

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

307

1152

1.78

18.61

1.1

—

(3036603) Volume of Urine

363

1433

1.69

18.42

1.7

1.6

1959.6

1951.7

0.03

336

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

272

989

1.83

18.28

1.9

2.5

u/ml

1255.4

1176.0

0.13

265

978

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

305

1149

1.77

18.26

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

144

413

2.32

18.17

2.8

3.0

mg/l

7.2

7.8

0.45

119

323

(3043410) Blood group antigens tested for on Red Blood Cells

157

469

2.23

18.04

2.2

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

514

2230

1.54

17.78

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

589

2633

1.49

17.71

1.6

1.5

58.1

58.7

0.12

391

1657

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3137

17688

1.19

17.66

4.5

3.7

mmol/l

1.2

0.85

2795

15321

(3028271) Lactate [Moles/volume] in Capillary blood

701

3245

1.44

17.65

2.0

1.8

mmol/l

1.7

1.8

1.93

687

3155

(3038026) Centromere Ab [Units/volume] in Serum

375

1512

1.65

17.60

1.2

u/ml

62.3

52.8

0.15

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

373

1504

1.65

17.51

1.8

1.7

—

(3039000) Anion gap in Blood

947

4627

1.37

17.47

7.1

6.4

mmol/l

11.3

11.1

1.16

876

4174

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

283

1057

1.78

17.46

1.8

1.7

—

(3018572) Chloride [Moles/volume] in Blood

947

4628

1.37

17.44

7.1

6.4

mmol/l

105.0

105.2

0.36

876

4175

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

448

1902

1.57

17.07

1.2

1.1

iu/ml

1.9

1.3

0.49

(4306422)

597

2700

1.48

16.97

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4649

27169

1.15

16.74

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

794

3800

1.40

16.62

3.7

3.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

530

2350

1.50

16.61

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

595

2708

1.47

16.40

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

126

357

2.35

16.39

1.1

umol/24h

0.7

0.9

0.66

188

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

346

1393

1.66

16.38

1.2

—

(40768446) Kidney Pathology biopsy report

212

738

1.91

16.34

1.8

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2163

11860

1.22

16.30

1.2

iu/ml

134.2

144.5

0.54

782

4553

(1002224) Polysomnography panel

1535

8103

1.27

16.28

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

347

1403

1.65

16.16

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

578

2625

1.47

16.12

1.1

121.8

118.4

1.41

517

2362

(3047189) Immunofixation for 24 hour Urine

263

986

1.78

16.08

1.9

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

345

1395

1.65

16.07

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

346

1402

1.64

15.99

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

344

1392

1.65

15.98

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

346

1403

1.64

15.95

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

574

2609

1.47

15.94

1.8

89.6

89.5

0.11

562

2570

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

232

2.67

15.70

1.3

nmol/l

6.6

369355.9

2.13

199

(3036670) Protein [Mass/volume] in Synovial fluid

179

596

2.00

15.69

1.3

1.2

g/l

39.1

40.5

0.51

325

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

448

1941

1.54

15.66

1.2

1.1

93.9

97.4

1.85

410

1819

(3025315) Body weight

133

3.25

15.38

5.0

4.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

234

859

1.81

15.35

1.6

umol/l

9.7

12.6

0.64

183

600

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

295

1160

1.69

15.29

2.1

2.6

e6/l

553.9

506.8

0.56

255

979

(40768441) Liver Pathology biopsy report

345

1414

1.63

15.27

1.6

1.3

—

(3011412) CD3 cells [#/volume] in Blood

409

1748

1.56

15.21

2.1

2.4

e9/l

1.1

0.26

249

1082

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

142

438

2.16

15.20

2.0

1.6

mg/l

8.7

9.3

0.58

118

348

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

131

392

2.22

15.09

2.3

2.5

au/ml

152.5

152.9

0.00

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

316

1274

1.65

14.93

2.2

2.6

e6/l

635.4

639.8

0.03

126

522

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

356

1482

1.60

14.81

1.2

u/ml

29.9

47.1

1.04

109

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

254

967

1.75

14.79

2.6

1.8

96.1

97.9

0.30

244

916

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

601

2798

1.43

14.76

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

355

1479

1.60

14.73

1.2

u/ml

60.2

76.5

0.42

(3028308) Erythrocytes [#/volume] in Pleural fluid

524

2378

1.47

14.72

1.5

1.4

e6/l

69724.8

56503.9

0.31

312

1430

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

221

810

1.82

14.60

2.5

2.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

568

2626

1.44

14.50

1.5

e6/l

2536.4

3469.1

0.72

407

1914

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

120

353

2.26

14.41

1.6

au/ml

165.0

104.0

0.41

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

280

1107

1.68

14.27

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

386

1653

1.56

14.26

1.9

1.8

mg/l

4.4

3.8

1.89

364

1580

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

553

2560

1.44

14.03

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

280

1113

1.68

14.00

2.2

2.6

e9/l

0.2

0.08

249

974

(43055442) Apixaban [Mass/volume] in Serum or Plasma

251

2.49

13.94

1.5

ug/l

117.4

119.4

0.05

207

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

255

2.48

13.94

1.3

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

169

577

1.95

13.87

1.5

1.4

umol/l

2.1

2.0

1.00

157

547

(4268621)

405

1765

1.53

13.85

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

325

1351

1.60

13.65

1.6

1.7

—

(3042631) Mycobacterium sp identified in Specimen

625

2974

1.40

13.63

2.6

—

(3051593) INR in Capillary blood by Coagulation assay

252

981

1.71

13.61

10.6

10.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

768

3783

1.35

13.57

1.9

1.8

pmol/l

190.2

200.9

2.36

709

3576

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

333

1398

1.59

13.43

1.0

mg/l

295.2

499.2

0.48

281

1271

(3010370) Gastrin [Moles/volume] in Serum or Plasma

256

2.44

13.40

1.4

1.9

pmol/l

34.6

77.4

1.55

215

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

204

750

1.81

13.40

1.6

1.7

nmol/l

3.5

7.0

0.56

168

638

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

335

1413

1.58

13.26

1.2

u/ml

16.8

5.7

0.58

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

492

2255

1.45

13.19

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

246

2.46

13.19

2.7

2.6

pmol/l

81.0

64.0

0.59

217

(3003434) Protein [Mass/volume] in Pleural fluid

618

2956

1.39

13.10

1.5

1.4

g/l

31.0

33.3

4.00

550

2660

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

249

978

1.70

13.05

3.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

114

344

2.20

12.95

1.1

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

267

1071

1.66

12.94

2.6

2.9

37.9

38.2

0.07

359

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

155

527

1.96

12.92

2.9

1.8

189.5

182.1

0.32

150

500

(3004775) Volume in Urine collected for unspecified duration

399

1765

1.51

12.78

2.4

2.2

662.5

675.8

0.27

289

1167

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

268

1085

1.64

12.56

1.6

1.4

u/l

5.5

6.1

0.53

225

920

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

303

1266

1.59

12.51

1.6

1.5

u/l

6.8

6.4

0.16

156

596

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

895

4571

1.31

12.38

1.7

1.8

iu/l

3.9

14.9

1.26

271

1645

(3006442) Creatine [Moles/volume] in Serum or Plasma

311

1312

1.58

12.34

1.7

1.5

umol/l

67.0

71.8

0.60

106

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1832

10171

1.21

12.20

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

319

1358

1.56

12.18

2.0

ug/l

3.7

3.5

0.15

281

1199

(3018851) Theophylline [Moles/volume] in Serum or Plasma

162

2.75

12.09

1.6

1.7

umol/l

47.3

44.5

0.25

162

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

919

4729

1.30

12.03

1.3

mg/l

531.7

573.6

1.33

880

4515

(3004451) EKG impression Narrative

252

1016

1.65

12.02

1.3

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

267

1093

1.63

12.00

1.1

iu/ml

6.9

9.8

1.53

262

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

175

637

1.83

11.93

1.5

1.3

umol/l

29.9

0.02

168

612

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

408

1841

1.48

11.91

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

823

4179

1.31

11.89

1.5

1.4

pmol/l

146.7

153.4

0.17

799

4091

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

820

4162

1.31

11.88

1.4

e6/l

3307.9

1694.1

0.27

666

3396

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1640

9046

1.21

11.70

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

532

2531

1.40

11.69

1.3

1.2

—

(4146454)

496

2331

1.42

11.69

2.7

—

(4024509)

409

1854

1.47

11.68

1.7

1.5

—

(3025577) Chromium [Mass/volume] in Blood

310

1325

1.56

11.66

2.1

2.0

ug/l

2.2

2.3

0.09

267

1115

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

817

4158

1.31

11.62

1.3

1.4

e6/l

31.6

34.4

0.06

626

3225

(3008898) HLA-B27 [Presence]

1040

5462

1.27

11.61

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

283

2.26

11.57

5.5

5.0

ug/min

49.7

47.6

0.13

227

(3052592) Norovirus Ag [Presence] in Stool

110

344

2.13

11.51

1.4

1.2

—

(3024471) HLA-A [Type]

177

655

1.80

11.47

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

316

1363

1.54

11.43

1.8

2.0

15.5

15.4

0.04

142

544

(1175426) CD3 cells/100 lymphocytes in Blood

321

1390

1.54

11.41

1.9

2.0

72.1

71.8

0.13

306

1331

(3030905) Polymorphonuclear cells [#/volume] in Blood

768

3886

1.32

11.40

3.5

3.2

e9/l

4.2

4.1

0.64

768

3873

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

994

5206

1.27

11.36

1.8

1.7

nmol/l

41.6

42.3

0.50

951

5067

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

558

2692

1.38

11.31

2.0

2.3

32.1

32.9

2.85

553

2671

(3024263) Appearance of Synovial fluid

270

1126

1.60

11.29

1.5

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

242

983

1.64

11.25

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

199

767

1.73

11.24

1.0

1.1

u/ml

5.8

6.0

0.03

129

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

332

1454

1.52

11.22

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

186

705

1.76

11.14

2.2

2.0

ug/l

58.0

55.1

0.19

180

693

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

389

1764

1.47

11.11

2.0

u/field

2.3

2.4

0.05

164

707

(4212803)

170

2.62

11.09

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

814

4169

1.30

11.08

1.2

1.3

mmol/l

3.8

0.06

760

3932

(3009214) Lutropin [Units/volume] in Serum or Plasma

759

3851

1.31

11.06

1.4

1.3

u/l

11.6

11.7

0.07

620

3130

(3003129) Base excess in Capillary blood by calculation

141

492

1.91

10.98

1.7

mmol/l

0.5

0.7

0.14

132

467

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

100

307

2.17

10.98

2.7

2.5

mg/l

131.6

67.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

145

512

1.88

10.91

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

568

2767

1.37

10.87

1.8

1.9

ug/l

21.1

24.4

0.60

552

2714

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.25

10.78

2.3

2.2

—

(3024932) HLA-DR beta [Type]

172

644

1.78

10.75

1.0

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

213

848

1.67

10.72

3.8

3.2

mu/l

31.7

26.3

1.07

204

802

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

257

1074

1.59

10.69

1.1

nmol/l

5.0

6.2

0.20

208

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

195

759

1.71

10.67

1.8

umol/l

85.8

128.3

1.91

104

391

(3036782) Glucose [Moles/volume] in Pleural fluid

433

2026

1.42

10.52

1.4

1.3

mmol/l

6.4

6.3

0.14

400

1869

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

287

2.18

10.48

1.1

1.2

—

(3016750) Collection duration of Urine

294

1274

1.54

10.47

2.4

2.1

min

494.3

497.5

0.25

240

906

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

106

340

2.07

10.45

1.8

2.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

249

1040

1.59

10.40

2.0

2.2

ug/min

138.0

108.1

0.27

237

(3001186) Copper [Moles/volume] in Serum or Plasma

119

400

1.98

10.35

1.3

1.2

umol/l

16.7

17.1

0.41

108

359

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

306

2.13

10.35

1.6

—

(44813793)

291

1266

1.53

10.19

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

274

2.18

10.12

4.7

5.3

—

(44806420)

162

612

1.76

9.88

2.4

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

367

1688

1.45

9.81

2.3

2.4

—

(3023410) Appearance of Cerebral spinal fluid

397

1853

1.43

9.81

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

333

1504

1.47

9.78

1.4

u/l

13.2

12.7

0.59

319

1454

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

241

1020

1.57

9.56

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

241

1020

1.57

9.56

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

241

1020

1.57

9.56

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

241

1020

1.57

9.56

1.7

1.9

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

191

764

1.66

9.51

1.4

1.3

umol/l

22.3

26.4

1.11

184

724

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

431

2054

1.40

9.49

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

147

547

1.79

9.45

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

240

1018

1.57

9.44

1.5

1.6

mmol/24h

5.3

5.6

0.11

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

157

597

1.75

9.39

1.7

2.0

29.0

30.0

0.28

147

560

(3018133) Calcium [Moles/volume] in Urine

241

2.21

9.27

1.3

1.6

mmol/l

2.2

2.8

2.03

210

(3006245) CD3-CD19+ cells/100 cells in Blood

156

595

1.74

9.24

1.8

2.1

10.4

0.02

143

541

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

356

1648

1.44

9.23

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

208

2.30

9.19

1.3

mmol/l

5.6

6.7

0.79

108

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

291

1296

1.49

9.19

1.9

2.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

539

2679

1.34

9.15

1.1

au/ml

11.9

11.1

0.07

135

(3045788) Cell count panel - Pleural fluid

426

2040

1.39

9.14

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

232

985

1.57

9.11

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

467

2272

1.37

9.10

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

160

2.49

9.08

1.3

1.2

ug/l

77.2

117.6

1.52

106

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

801

4208

1.27

9.03

1.5

1.8

nmol/l

0.9

0.8

2.66

675

3526

(3001019) Free T4 and TSH panel - Serum or Plasma

1177

9413

0.83

9.02

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

191

778

1.63

8.91

2.7

2.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

266

1171

1.51

8.89

1.9

1.8

u/field

2.0

2.7

0.51

181

825

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

287

1284

1.49

8.88

1.4

umol/l

14.1

12.8

1.94

273

1218

(3019420) Tryptase [Mass/volume] in Serum or Plasma

222

944

1.56

8.69

1.5

1.6

ug/l

7.0

9.1

1.69

206

862

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

845

0.45

8.67

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

141

533

1.76

8.65

1.7

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

195

806

1.61

8.60

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

164

650

1.68

8.51

1.3

1.4

59.1

56.4

0.41

141

557

(3044290) Cell count panel - Cerebral spinal fluid

744

3904

1.27

8.50

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

423

2051

1.37

8.46

1.5

28.2

29.7

0.37

278

1265

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

278

1250

1.48

8.43

2.4

1.8

nmol/l

16.8

16.2

0.49

261

1170

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

182

745

1.63

8.36

3.0

1.7

173.2

152.5

2.06

173

697

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

134

506

1.76

8.27

3.7

1.8

ug/l

1.1

1.0

0.37

126

482

(3019977) pH of Arterial blood

252

1115

1.50

8.27

2.6

2.4

7.4

0.35

108

408

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

128

477

1.78

8.26

1.6

1.5

ug/l

0.4

0.08

300

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

388

1863

1.39

8.25

1.3

nmol/l

1.6

1.4

1.77

349

1684

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

213

909

1.56

8.24

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

470

2328

1.34

8.22

5.8

6.4

mmol/l

7.4

7.6

0.36

366

1909

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

215

920

1.55

8.22

2.4

2.7

ug/l

25.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

597

3061

1.30

8.20

1.6

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

135

513

1.75

8.16

1.4

g/l

14.1

12.9

0.66

394

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

290

1324

1.46

8.16

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

112

403

1.85

8.09

1.2

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

339

1598

1.41

8.03

1.9

2.1

37.8

39.6

0.28

204

(3017569) Oxygen content in Arterial blood

223

970

1.53

7.94

2.3

2.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

239

1059

1.50

7.82

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

405

1977

1.36

7.81

1.3

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

410

2008

1.36

7.75

1.3

u/l

344.4

511.2

2.28

388

1902

(40762887) Creatinine [Moles/volume] in Blood

4.30

7.71

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

117

435

1.79

7.64

2.0

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

140

549

1.70

7.61

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

794

0.47

7.61

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

793

0.47

7.58

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

791

0.47

7.53

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

791

0.47

7.53

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

288

1335

1.44

7.52

1.5

1.4

—

(3033799) Differential panel - Peritoneal fluid

154

622

1.65

7.51

1.7

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

342

1636

1.39

7.48

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

230

1021

1.50

7.48

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

392

1921

1.36

7.41

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

673

0.43

7.35

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

963

5290

1.21

7.32

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

317

1.91

7.30

3.6

2.7

ml/dl

14.2

15.1

2.02

293

(3005033) Fetal Nuchal fold Thickness US

670

0.44

7.27

1.4

—

(3010503) CD19 cells [#/volume] in Blood

257

1175

1.46

7.24

2.3

2.5

e9/l

0.2

0.4

1.40

249

1140

(3016018) Differential panel - Cerebral spinal fluid

415

2061

1.34

7.20

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.97

7.18

1.4

1.6

u/l

0.0

0.1

0.48

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

180

765

1.57

7.16

1.4

60.9

63.6

0.41

142

630

(3043238) Trisomy 21 risk [Likelihood] in Fetus

701

0.45

7.11

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

142

571

1.65

7.07

1.3

1.2

umol/l

2.8

3.2

0.79

127

524

(3045683) HLA typing for celiac disease panel - Blood or Tissue

203

889

1.52

7.07

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

115

437

1.75

7.03

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

685

3663

1.25

6.77

1.6

1.7

—

(3035880) pH of Pleural fluid

256

1186

1.44

6.76

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

156

2.26

6.61

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

845

4634

1.22

6.58

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

151

629

1.60

6.58

1.7

1.6

u/ml

5734.6

37889.9

0.83

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

187

819

1.52

6.55

1.9

2.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

152

637

1.59

6.46

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

134

545

1.63

6.43

2.6

3.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

386

1933

1.33

6.39

1.6

1.8

titre

684.4

2488.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

316

1538

1.37

6.31

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

106

408

1.73

6.25

1.6

2.0

e6/l

807.3

1494.2

0.37

203

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

145

610

1.58

6.10

1.3

1.2

g/l

0.3

0.72

115

486

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

136

564

1.60

6.07

1.3

1.2

110.1

113.0

0.47

117

502

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

182

807

1.50

6.05

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

182

808

1.50

6.02

1.9

2.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.40

6.00

1.1

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

147

624

1.57

5.96

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

233

1088

1.42

5.96

1.2

1.1

u/l

79.8

87.1

0.74

197

841

(40761539) Cells [Type] in Urine sediment by Light microscopy

123

500

1.64

5.95

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

148

630

1.56

5.93

1.4

pmol/l

15.8

15.4

0.30

122

532

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

233

1090

1.42

5.90

1.2

1.1

u/l

22.7

25.4

0.35

193

804

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.08

5.88

1.4

1.8

ug/l

186.2

107.3

0.71

(3000919) Neutrophils/100 leukocytes in Pleural fluid

140

591

1.58

5.83

1.4

20.3

21.6

0.21

121

539

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.58

5.82

1.9

1.8

umol/l

1.3

1.4

0.20

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

219

1.97

5.82

1.2

1.1

—

(3012565) Volume of 24 hour Urine

225

1049

1.43

5.82

2.1

2.3

1921.9

1976.1

0.25

201

926

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

144

2.22

5.77

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

144

2.22

5.77

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

109

433

1.67

5.77

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

157

2.16

5.77

2.1

2.2

58.6

62.6

0.27

102

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

106

418

1.69

5.77

2.4

2.6

mmol/l

7.3

7.5

0.18

237

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

319

1580

1.34

5.75

1.3

u/l

13.8

13.6

0.04

296

1466

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

151

651

1.54

5.74

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

2.52

5.70

1.1

1.3

—

303.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

199

2.00

5.62

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

129

2.27

5.59

4.3

4.9

—

(4034850)

1208

6940

1.16

5.58

13.4

9.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

348

1759

1.32

5.48

4.3

5.1

u/ml

141.0

101.0

0.32

535

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.18

5.47

1.1

1.0

u/ml

17.2

31.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

169

758

1.48

5.38

1.2

—

(40768806) Pleura Pathology biopsy report

445

2331

1.27

5.35

1.6

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

333

1.74

5.30

1.1

1.4

titre

17.7

249.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

161

1553

0.69

5.19

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

387

1.67

5.11

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

101

2.37

5.07

1.0

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

135

2.17

5.07

1.4

1.2

mg/l

44.6

45.4

0.09

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

123

523

1.56

5.03

1.2

1.1

104.9

104.5

0.04

114

481

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

114

2.27

5.03

1.1

—

(3028433) Virus identified in Specimen by Culture

142

624

1.51

5.01

1.1

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

207

979

1.41

5.01

2.0

2.6

u/l

215.6

208.2

0.46

207

971

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

158

2.06

4.99

5.6

5.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

129

556

1.54

4.98

1.8

2.1

u/l

30.0

41.1

0.41

123

498

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

102

2.34

4.97

1.8

1.5

mg/l

1.7

2.2

0.24

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

2.2

2.3

0.02

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

1.5

2.3

0.68

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

1.4

2.6

0.78

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

0.6

1.0

0.52

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

2.5

1.1

0.52

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

4.1

3.4

0.22

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

1.2

3.0

1.38

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

1.2

3.9

2.03

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.35

4.86

1.8

1.5

mg/l

2.9

1.7

0.38

(3023323) Follitropin [Units/volume] in Serum or Plasma

899

6951

0.86

4.84

1.4

1.3

iu/l

34.1

37.4

2.24

790

6041

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.10

4.83

1.1

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

125

2.18

4.81

2.1

2.2

18.5

17.3

0.06

(3050129) First trimester maternal screen panel - Serum or Plasma

949

0.62

4.71

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

216

1041

1.38

4.71

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

165

758

1.45

4.71

2.0

1.9

e6/l

2080.7

4261.5

0.60

106

519

(21491868) Cryoglobulin [Mass/volume] in Serum

148

668

1.47

4.63

1.2

g/l

1.8

0.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

224

1092

1.36

4.57

1.1

ratio

1.1

0.11

380

(3034426) Prothrombin time (PT)

138

618

1.48

4.50

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

173

810

1.42

4.48

1.7

2.4

ug/l

21.8

308.5

1.44

168

768

(3037692) Legionella sp identified in Specimen by Organism specific culture

161

744

1.44

4.48

1.6

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

108

459

1.56

4.48

1.4

1.3

g/l

24.8

41.8

0.71

357

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

117

507

1.53

4.46

1.2

1.1

86.9

86.4

0.05

256

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

148

675

1.46

4.42

2.0

1.8

e6/l

6988.1

10505.6

0.47

364

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

262

1.75

4.39

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

171

1.94

4.39

2.7

2.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

362

1901

1.27

4.36

1.5

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

338

1.65

4.35

1.3

1.2

81.8

76.8

0.31

106

(3016330) Potassium [Moles/time] in 24 hour Urine

273

1.73

4.34

1.2

1.3

mmol/24h

79.8

87.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

209

1019

1.36

4.29

3.5

3.8

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.41

4.28

1.0

u/ml

0.0

0.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1301

7665

1.13

4.27

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.29

4.23

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

161

753

1.42

4.23

6.3

6.4

mmol/l

25.2

25.1

0.14

144

681

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

277

1412

1.30

4.22

1.6

1.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

393

1.59

4.20

1.4

1.2

mg/l

88.1

29.2

0.43

288

(3001893) Eosinophils/100 leukocytes in Pleural fluid

144

663

1.44

4.12

1.4

2.2

2.6

0.39

115

559

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

237

1187

1.33

4.10

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

236

1182

1.33

4.09

1.6

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

339

1.63

4.09

1.2

92.2

88.4

0.21

114

(4281824)

412

2215

1.24

4.07

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

205

1006

1.36

4.07

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

121

2.09

4.06

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.39

3.95

1.4

1.3

—

(40757373) Influenza virus identified in Isolate

400

1.56

3.93

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

165

789

1.39

3.86

1.9

2.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

273

1.68

3.85

2.3

2.1

—

(3012898) Urea [Moles/volume] in Urine

199

1.80

3.84

1.4

mmol/l

156.5

171.7

0.42

172

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

206

1023

1.34

3.81

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

246

1.70

3.70

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

187

1.81

3.70

1.4

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

115

520

1.47

3.66

1.2

1.1

85.4

86.7

0.15

260

(3044242) Glucose [Moles/volume] in Arterial blood

199

990

1.34

3.66

2.0

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

304

1.62

3.61

1.1

1.2

ng/l

1194.0

131.2

0.49

212

(3028717) Thiamine [Mass/volume] in Blood

184

1.81

3.60

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.15

3.58

4.3

5.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

269

1401

1.28

3.55

1.2

1.3

u/ml

1.5

0.01

124

677

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

142

1.92

3.54

1.1

u/l

5.3

12.0

2.14

142

(40762814) Titanium [Mass/volume] in Blood

374

1.55

3.52

2.3

ug/l

3.5

4.1

0.50

125

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.19

3.52

1.0

u/ml

0.1

0.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

171

1.83

3.51

1.2

1.3

ml/s/173m2

1.2

1.1

0.21

103

(3027923) C peptide [Moles/volume] in Serum or Plasma

211

1067

1.31

3.49

1.5

1.4

nmol/l

1.3

0.26

156

821

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

318

1.59

3.46

1.3

1.4

10.1

11.8

0.22

161

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.85

3.43

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

4.15

3.41

1.2

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

420

1.50

3.40

1.7

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.72

3.39

1.1

1.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.12

3.39

2.2

2.4

mg/l

1.8

2.1

0.42

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

326

1.57

3.35

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

196

988

1.32

3.33

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

477

1.46

3.31

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

283

1501

1.25

3.25

1.0

ng/l

41.1

43.1

0.31

193

1047

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

350

1.54

3.24

2.4

3.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.93

3.21

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

147

714

1.37

3.21

1.1

miu/ml

1695.7

1500.2

1.18

147

714

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

282

1498

1.25

3.20

1.0

ng/l

785.4

728.3

1.06

189

1030

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

252

1.63

3.20

1.7

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

294

1.58

3.17

1.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

116

1.95

3.11

1.2

1.7

umol/l

0.9

0.7

0.41

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

249

1.63

3.10

1.4

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

280

1494

1.25

3.08

1.0

ng/l

318.9

347.2

0.45

192

1062

(3044007) Cell count panel - Peritoneal fluid

127

607

1.39

3.07

2.0

1.9

—

(44806071)

230

1.65

3.04

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

361

1.51

3.04

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

556

4285

0.86

3.03

1.6

1.7

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.77

2.94

1.1

g/l

0.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

197

1.69

2.92

2.4

2.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

187

1.71

2.92

1.1

umol/24h

1.8

0.08

187

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

350

1.50

2.87

1.8

1.9

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

583

0.64

2.84

2.2

2.4

nmol/l

141.8

151.0

0.15

505

(3011335) Digoxin [Mass/volume] in Serum or Plasma

169

1.73

2.82

2.7

2.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

135

1.82

2.81

2.8

3.2

pmol/l

36.6

483.3

0.49

(3021387) Prolactin [Units/volume] in Serum or Plasma

679

3955

1.14

2.80

1.8

mu/l

275.0

298.6

1.39

629

3621

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

116

1.89

2.80

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

102

1.95

2.79

4.8

3.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

445

1.43

2.79

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

278

1.55

2.77

2.9

2.5

u/field

0.5

0.15

278

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

103

485

1.41

2.75

1.2

1.3

nmol/l

111.8

128.6

0.56

356

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

275

1486

1.23

2.74

1.2

mmol/l

11.8

12.1

0.29

114

449

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

185

954

1.29

2.74

1.2

mmol/l

5.9

6.0

0.65

175

893

(3005011) Chlamydia sp Ab [Titer] in Serum

232

1.60

2.73

1.7

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

156

1.75

2.73

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

181

1.69

2.73

1.6

1.4

—

14.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

453

1.42

2.72

1.1

1.2

titre

288.0

688.6

—

(3044009) aPTT.lupus sensitive (LA screen)

137

1.79

2.69

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

202

1057

1.27

2.68

1.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

162

1.72

2.67

1.8

1.7

mg/l

1.9

1.6

0.43

133

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

265

1.55

2.67

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.99

2.67

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

701

0.68

2.66

1.4

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

208

1.63

2.65

2.3

2.0

—

(3019174) dRVVT (LA screen)

133

1.80

2.64

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.96

2.64

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

114

552

1.37

2.61

1.6

1.7

ug/l

9.6

8.8

1.44

114

552

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

124

1.82

2.60

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

138

689

1.33

2.60

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

105

1.90

2.60

1.2

1.4

umol/24h

387.7

343.8

0.34

105

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

337

1870

1.20

2.59

1.1

au/ml

110.2

62.1

—

(3000285) Sodium [Moles/volume] in Blood

262

1.55

2.58

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

121

594

1.35

2.55

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

194

0.41

2.55

1.2

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

270

1469

1.22

2.55

1.2

1.3

mmol/l

2.2

0.06

247

1363

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

100

476

1.40

2.54

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

180

1.66

2.54

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

192

1.63

2.46

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.98

2.44

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

300

1661

1.20

2.40

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

111

544

1.36

2.39

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

289

1595

1.20

2.39

2.2

2.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

285

1571

1.21

2.39

1.4

promille

1.4

1.3

0.21

215

1204

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.08

2.35

1.3

1.1

nmol/l

261.8

290.0

0.28

(44786800) Granulocytes/100 leukocytes in Body fluid

274

1.50

2.34

1.2

1.3

23.9

24.6

0.06

210

(3024316) Viscosity of Plasma

1.89

2.33

2.2

1.8

mpas

1.5

1.8

1.40

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

275

1.50

2.31

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

275

1.50

2.31

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

274

0.53

2.29

1.0

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

165

1.65

2.29

1.1

1.3

nmol/l

0.2

0.3

0.34

114

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

123

618

1.32

2.27

1.0

1.1

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

4.23

2.25

5.7

6.5

10.7

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

930

5601

1.11

2.25

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

293

1.47

2.25

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

483

1.36

2.22

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.66

2.22

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

111

552

1.34

2.21

1.5

1.3

35.7

38.9

0.35

380

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.21

2.20

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

107

1.80

2.19

1.1

u/l

41.3

111.2

0.61

(3027008) Opiates [Presence] in Urine

517

3896

0.88

2.16

1.8

—

(3028300) Cannabinoids [Presence] in Urine

519

3910

0.88

2.16

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

450

0.65

2.15

1.3

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.32

2.15

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

275

1.47

2.13

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

391

1.39

2.12

1.2

mmol/l

1.5

1.7

0.48

243

(3000764) Benzodiazepines [Presence] in Urine

515

3875

0.88

2.11

1.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.47

2.11

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

510

3836

0.88

2.08

1.7

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

155

817

1.26

2.03

1.0

1.1

101.3

99.0

0.38

124

643

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

115

1.73

2.02

1.2

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

198

1.54

2.00

1.1

1.2

—

(40768793) Breast Pathology biopsy report

777

4671

1.11

2.00

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.94

1.98

6.4

9.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

173

0.46

1.97

3.7

3.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

392

1.37

1.95

1.2

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

172

0.46

1.95

7.3

6.0

—

(3009871) Measles virus Ab [Titer] in Serum

128

663

1.28

1.94

1.6

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

485

1.33

1.91

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

394

1.37

1.90

1.1

1.0

u/ml

0.5

0.9

0.48

197

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

373

1.37

1.86

1.0

1.1

pmol/l

2.2

7.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

129

674

1.27

1.85

1.9

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.32

1.84

1.6

1.1

nmol/l

345.3

272.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

111

570

1.29

1.82

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.72

1.82

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

211

0.53

1.81

1.1

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.90

1.80

1.1

1.0

pmol/l

138.1

134.2

0.05

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

421

1.34

1.80

1.1

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

127

665

1.27

1.80

1.4

1.3

mmol/l

3.3

3.5

0.20

116

609

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

135

1.62

1.79

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

177

1.54

1.79

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.83

1.78

1.2

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

226

1.47

1.77

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.80

1.77

1.3

1.5

u/field

1.0

1.1

0.41

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

183

1.52

1.77

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

229

1282

1.19

1.73

5.8

6.5

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.84

1.73

1.0

1.2

ng/l

1348.9

2552.2

1.40

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

116

1.66

1.72

1.1

u/field

1.0

1.1

1.29

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.78

1.71

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

362

1.36

1.71

1.8

6.2

u/l

51.8

47.5

0.13

147

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

121

1008

0.80

1.69

1.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.28

1.68

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

419

2464

1.13

1.65

1.2

mmol/l

7.3

7.6

1.14

296

1799

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

497

1.30

1.65

6.4

4.8

66.2

71.3

0.97

406

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.90

1.64

1.1

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.03

1.63

1.4

1.2

nmol/l

375.6

630.6

1.26

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.21

1.59

1.0

1.1

2.8

2.3

0.24

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

518

1.28

1.58

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

109

571

1.27

1.58

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

109

1.65

1.57

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

437

1.31

1.57

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

616

0.75

1.54

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

267

1.39

1.54

1.0

—

1.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

147

1.54

1.51

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

147

1.54

1.51

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

144

783

1.22

1.51

2.2

2.3

umol/l

58.7

55.0

0.62

106

639

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.02

1.51

6.4

9.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.49

1.49

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

215

1217

1.17

1.48

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

484

1.28

1.45

1.0

1.1

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.98

1.44

1.0

u/l

655.4

294.0

0.31

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

120

0.50

1.44

4.3

6.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

161

891

1.20

1.44

1.3

1.2

55.5

57.6

0.08

108

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.58

1.43

1.7

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

116

621

1.24

1.43

1.3

ug/l

129.8

203.3

0.48

346

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

198

1118

1.18

1.41

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

150

1.51

1.40

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

194

1.44

1.39

1.5

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

262

1.37

1.8

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

274

1591

1.14

1.37

1.2

—

(3022689) Creatine [Moles/volume] in Urine

118

637

1.23

1.36

1.4

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

145

800

1.20

1.35

1.1

ng/l

355.7

604.2

0.38

189

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

515

3107

1.10

1.35

1.1

iu/ml

27487.4

510.1

0.54

622

(3016273) Islet cell 512 Ab [Units/volume] in Serum

102

0.46

1.35

1.1

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.21

1.35

1.0

1.1

—

(3000012) Reticulocyte production index

213

1216

1.16

1.34

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

396

1.29

1.33

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

104

1.60

1.33

1.5

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

146

808

1.20

1.33

1.1

u/ml

3.1

15.0

1.31

(3001729) Color of Synovial fluid

180

1.44

1.31

1.2

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

190

1079

1.17

1.29

1.1

—

(3016879) Cocaine [Presence] in Urine

493

3597

0.91

1.29

1.8

1.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

948

5881

1.07

1.29

1.7

—

(40768795) Lymph node Pathology biopsy report

369

2194

1.12

1.29

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

517

1.25

1.27

1.5

1.4

21.1

22.8

0.27

431

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

198

1.41

1.27

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

376

1.29

1.26

1.5

1.7

ug/l

2.0

3.0

0.69

213

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

618

0.78

1.25

1.6

1.7

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

155

1.46

1.23

2.3

2.5

mmol/l

0.9

0.13

101

(3009677) Dengue virus Ab [Presence] in Serum

1.77

1.23

1.4

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

390

1.28

1.22

1.6

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

382

2286

1.11

1.20

1.4

1.3

u/l

33.7

36.5

0.89

294

1863

(3035611) Eosinophils/100 leukocytes in Synovial fluid

151

1.45

1.18

1.2

1.7

1.0

0.6

0.42

121

(3049242) von Willebrand panel - Platelet poor plasma

1.78

1.17

1.9

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

399

1.27

1.16

1.1

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.45

1.15

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

142

797

1.18

1.15

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

394

1.26

1.14

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

2.55

1.12

1.0

1.3

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.55

1.12

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

255

1.33

1.12

1.6

1.4

73.5

70.9

0.26

213

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

104

1.53

1.11

1.2

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.32

1.11

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.32

1.11

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.32

1.11

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.32

1.11

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.32

1.11

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.32

1.11

2.0

—

(40768800) Prostate Pathology biopsy report

790

4909

1.07

1.08

1.2

—

(4198724)

481

1.23

1.08

1.4

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.85

1.07

1.3

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

241

0.69

1.04

1.2

2.3

mmol/l

6.8

7.4

0.64

110

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.37

1.03

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.72

1.01

1.1

—

(3015183) Erythrocyte sedimentation rate

152

871

1.16

0.99

1.6

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

146

1.41

0.99

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

493

1.21

0.98

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.63

0.97

1.0

1.1

umol/24h

0.4

0.6

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.77

0.95

7.1

8.3

29.6

51.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

550

1.20

0.94

6.8

7.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

176

1.36

0.94

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.94

0.94

1.0

u/ml

0.1

0.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.59

0.94

1.2

1.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.21

0.93

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.21

0.93

1.2

1.0

—

(3025130) Human papilloma virus identified in Specimen

349

2115

1.10

0.93

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

194

1.34

0.92

1.1

1.2

u/ml

0.1

1.9

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

104

1.47

0.91

1.0

1.1

u/l

1.4

3.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

282

1.27

0.91

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

468

2876

1.08

0.91

1.1

u/ml

1.0

1.4

0.49

165

1060

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.53

0.90

1.3

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.69

0.90

1.1

1.0

g/l

0.2

0.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

242

1.29

0.89

1.0

ug/l

90.1

82.1

0.57

197

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

1.40

0.88

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

173

1.34

0.87

1.3

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

223

1650

0.90

0.86

1.0

u/ml

0.1

0.4

2.22

345

(40763590) HLA-DQ beta [Type]

0.52

0.85

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

756

4738

1.06

0.85

4.4

3.2

mg/l

29.1

27.0

0.82

499

3040

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

133

768

1.15

0.83

2.7

3.0

umol/l

28.7

29.0

0.08

101

590

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

205

0.71

0.81

1.1

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

211

1.29

0.80

1.2

1.1

u/l

17.3

18.6

0.20

131

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

182

1.31

0.79

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

240

1758

0.91

0.79

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

158

928

1.13

0.78

1.1

u/l

1.0

1.1

2.58

468

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

434

1.19

0.77

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

103

1.42

0.76

1.5

1.6

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.08

0.74

1.2

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.08

0.74

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

448

2778

1.07

0.73

4.7

4.8

umol/l

350.6

364.9

1.31

391

2366

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

583

3648

1.06

0.73

3.4

3.6

u/ml

27.9

38.6

2.28

566

3518

(3008536) Aspergillus sp Ab [Presence] in Serum

413

1.19

0.72

1.8

2.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

162

1.31

0.71

1.2

1.3

pmol/l

10.8

13.6

0.38

140

(3034891) Synovial lining cells/100 cells in Synovial fluid

181

1081

1.11

0.70

1.5

3.0

4.2

0.64

236

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

618

1.15

0.70

2.6

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

618

1.15

0.70

2.6

2.4

—

(3014891) Appearance of Pleural fluid

312

1.21

0.69

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

671

0.86

0.68

1.4

1.8

ug/l

2.3

6.5

1.72

425

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

654

4117

1.06

0.68

1.3

miu/ml

203.6

217.8

0.38

233

1786

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

100

1.39

0.68

1.1

37.0

36.8

0.06

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

100

1.39

0.68

1.1

1.0

8.6

0.04

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.62

0.68

2.3

3.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

146

1.32

0.68

1.3

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.84

0.67

1.0

1.1

mmol/24h

143.5

151.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.66

0.67

2.2

2.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.40

0.66

1.3

1.2

g/l

0.1

0.75

(3038071) Oxygen [Partial pressure] in Mixed venous blood

480

1.16

0.65

7.0

7.6

—

(3046861) Legionella sp Ag [Presence] in Urine

125

1.33

0.62

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

262

1.22

0.61

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

114

1.34

0.61

1.3

1.1

—

(40758358) Immune stain study

1.37

0.60

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

257

1.21

0.60

2.2

1.9

umol/l

15.7

18.3

1.02

257

(3005082) Progesterone [Moles/volume] in Serum or Plasma

193

0.76

0.60

1.4

1.3

nmol/l

9.2

26.7

4.60

154

(46236302) HLA-C [Type] by High resolution typing

0.61

0.59

1.0

—

(40760409) HLA-A [Type] by High resolution

0.61

0.59

1.0

—

(40760410) HLA-B [Type] by High resolution

0.61

0.59

1.0

—

(3013862) HLA-DP [Type]

0.60

0.59

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.37

0.58

11.3

8.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.58

0.57

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

219

1339

1.09

0.57

1.1

mg/l

39.1

45.8

1.59

193

1111

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.66

0.56

1.2

1.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

157

1.27

0.56

1.2

14.3

25.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

116

1.32

0.56

1.2

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

128

1.30

0.55

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.59

0.54

1.0

titre

1581.7

2064.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

237

1.21

0.52

2.6

3.1

mg/l

1.3

0.05

164

(4027681)

160

969

1.10

0.52

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

189

1.23

0.52

1.1

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

208

1278

1.08

0.50

1.1

mg/l

266.1

304.8

2.01

192

1109

(3018001) Oat IgE Ab [Units/volume] in Serum

1.34

0.50

1.1

1.0

u/ml

0.2

0.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.60

0.50

2.1

5.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

112

0.71

0.49

1.8

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.55

0.49

1.1

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

329

2058

1.06

0.49

3.0

mg/l

52.2

51.0

0.02

231

1479

(40758292) HTLV I+II Ab panel - Serum

307

1.17

0.48

1.4

1.5

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.50

0.48

5.3

6.6

mmol/l

0.2

0.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

513

1.13

0.48

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

513

1.13

0.48

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

513

1.13

0.48

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

513

1.13

0.48

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.39

0.47

1.9

1.4

—

(3018291) Platelet Ab [Presence] in Serum

1.45

0.46

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

107

785

0.90

0.45

1.0

u/ml

0.7

1.0

—

108

(3042517) Benzodiazepines panel - Urine

103

1.29

0.44

1.8

2.3

—

(3045716) Anion gap in Serum or Plasma

163

999

1.08

0.44

2.1

2.5

mmol/l

8.8

9.3

0.77

113

727

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

224

1.19

0.44

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

248

0.83

0.43

14.5

7.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1033

6658

1.03

0.43

1.7

mg/l

4.3

3.6

1.28

789

4765

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

153

0.78

0.42

1.7

2.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.40

0.42

1.3

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.41

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.72

0.39

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

281

0.85

0.39

5.9

7.7

umol/l

0.4

0.01

255

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.41

0.37

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

223

1.16

0.36

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

405

1.12

0.35

1.1

1.0

u/ml

8.1

10.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

113

1.23

0.35

1.0

1.1

—

1.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

169

1.18

0.33

2.4

2.5

—

(3013762) Body weight Measured

1.33

0.33

1.0

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.31

0.33

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

306

1941

1.05

0.32

1.4

nmol/l

0.3

0.18

222

1355

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.25

0.32

1.1

1.0

u/ml

0.0

0.3

1.06

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

190

0.84

0.32

1.1

—

(3003577) Lead [Moles/volume] in Blood

146

1.18

0.30

1.3

1.4

umol/l

0.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.76

0.29

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

178

1.16

0.29

1.0

1.1

iu/ml

18.1

15.2

0.13

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

348

1.11

0.28

2.2

3.2

ng/l

84.1

110.1

0.62

112

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

298

1.11

0.28

1.3

59.1

47.9

0.72

139

(3020618) Glucose [Moles/volume] in Synovial fluid

1.25

0.28

1.1

mmol/l

6.0

5.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

233

1481

1.05

0.25

1.4

1.3

pmol/l

68.0

98.2

0.76

475

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

1.22

0.25

1.7

1.8

umol/l

115.8

351.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

256

1.12

0.25

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

100

1.20

0.24

1.6

1.5

mmol/l

24.9

24.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.33

0.23

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.21

0.23

1.2

1.4

1.77

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.28

0.23

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

376

2421

1.03

0.23

2.0

2.7

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

124

870

0.95

0.22

10.3

12.4

mmol/l

0.6

1.47

114

792

(3020874) Milk IgE Ab [Units/volume] in Serum

145

916

1.05

0.22

1.1

1.0

u/ml

0.6

1.2

0.76

246

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

221

1.11

0.21

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

338

2315

0.97

0.21

1.0

1.1

u/ml

0.5

1.6

3.27

520

(3012989) Citrate [Moles/time] in 24 hour Urine

1.29

0.21

1.5

1.4

mmol/24h

1.1

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

399

2577

1.03

0.21

1.1

u/ml

1.8

3.5

4.78

176

1180

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.25

0.20

6.0

1.5

mu/l

1.4

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

517

1.07

0.20

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

395

2553

1.03

0.20

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.24

0.20

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

921

6013

1.02

0.19

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

187

0.89

0.19

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.22

0.18

1.0

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.21

0.18

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.16

0.18

1.0

—

12505.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

171

1093

1.04

0.17

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.18

0.17

1.0

1.3

—

(4133840)

568

1.05

0.16

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

393

2552

1.02

0.16

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

162

1115

0.96

0.15

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.15

0.15

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

163

0.90

0.15

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

388

0.94

0.14

6.9

7.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

141

0.89

0.13

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.85

0.13

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

380

2478

1.02

0.12

1.1

u/ml

0.5

1.0

3.08

132

954

(3023430) Cat dander IgE Ab [Units/volume] in Serum

281

1906

0.98

0.12

1.0

1.1

u/ml

2.4

3.0

0.30

106

720

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

608

1.04

0.11

1.2

26.2

25.8

0.01

105

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.07

0.09

1.0

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.04

0.09

2.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.14

0.09

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

204

1330

1.02

0.08

1.3

g/l

1.6

1.5

0.62

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

344

2254

1.01

0.08

3.3

3.8

u/ml

42.9

51.5

0.46

337

2227

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

420

0.96

0.07

1.1

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.04

0.07

1.1

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.83

0.07

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

302

2032

0.99

0.07

1.0

1.1

u/ml

1.6

3.6

3.21

107

730

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

287

1.04

0.06

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.87

0.06

1.0

u/ml

0.0

1.7

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.11

0.06

1.3

1.1

mg/l

0.0

0.1

2.17

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.11

0.06

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

334

1.03

0.05

1.3

1.4

mmol/l

9.2

8.8

0.18

196

(3013293) Extractable nuclear Ab [Presence] in Serum

309

0.97

0.05

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

432

2891

0.99

0.05

1.8

1.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

145

1.05

0.04

1.8

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

448

0.98

0.04

4.4

6.0

—

(3022475) Manganese [Moles/volume] in Blood

113

0.94

0.04

1.4

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.09

0.04

1.1

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

113

1.06

0.03

1.0

u/ml

0.0

0.35

(3042010) Triglyceride [Moles/volume] in Pleural fluid

324

1.02

0.03

1.4

1.3

mmol/l

1.4

1.6

0.09

219

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

273

0.97

0.03

1.5

1.3

u/l

34.3

302.9

1.00

205

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2050

13591

1.00

0.02

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

134

898

0.99

0.02

1.0

u/ml

0.7

1.4

0.57

212

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

345

0.98

0.02

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

138

0.96

0.01

1.3

1.5

18.2

12.6

0.37

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

158

0.97

0.01

1.3

1.5

25.6

42.3

1.03

104

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

117

0.96

0.00

1.2

1.4

0.4

2.1

2.11

(3017509) Phencyclidine [Presence] in Urine

130

0.97

0.00

1.5

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

104

1.02

0.00

1.0

u/ml

0.1

0.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

185

1.01

0.00

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

117

1.02

0.00

1.0

u/ml

0.0

0.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

107

0.99

0.00

1.4

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

219

1.00

0.00

1.0

1.1

u/ml

0.7

0.6

0.07

144

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

160

1066

1.00

0.00

4.9

5.2

u/ml

1376.5

3940.7

0.30

179

(3029396) Erythrocyte agglutination [Presence] in Blood

131

1.01

0.00

1.4

2.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

189

1.02

0.00

1.0

u/ml

0.1

0.6

0.65

132

(3001556) Androgen free Index in Serum or Plasma

1.01

0.00

1.1

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.91

0.00

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

2.2

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

1.6

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.97

0.00

1.0

1.3

—

1631.7

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.95

0.00

1.8

2.0

ng/l

16.1

9.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_DIVERTIC and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_DIVERTIC	1.166 [1.08, 1.26]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.089

During the follow-up period (1.1.1998 — 31.12.2019), 35139 out of 136211 females with K11_DIVERTIC died.

Males

Parameter	HR [95% CI]	p-value
K11_DIVERTIC	1.278 [1.17, 1.4]	< 0.001
Birth year	0.984 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 25793 out of 90442 males with K11_DIVERTIC died.

Mortality risk

Mortality risk for people of age

years, who have K11_DIVERTIC.

N-year risk	Females	Males
1	0.098%	0.174%
5	0.626%	1.202%
10	1.517%	3.079%
15	2.873%	5.976%
20	5.012%	9.993%

Relationships between endpoints

↥

Index endpoint: K11_DIVERTIC – Diverticular disease of intestine

GWS hits: 104

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diverticular disease of intestine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints